<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2022-09-19T18:02:10Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8316152" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8316152</identifier>
        <datestamp>2021-11-17</datestamp>
        <setSpec>iai</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Infect Immun</journal-id>
              <journal-id journal-id-type="iso-abbrev">Infect Immun</journal-id>
              <journal-id journal-id-type="publisher-id">iai</journal-id>
              <journal-title-group>
                <journal-title>Infection and Immunity</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0019-9567</issn>
              <issn pub-type="epub">1098-5522</issn>
              <publisher>
                <publisher-name>American Society for Microbiology</publisher-name>
                <publisher-loc>1752 N St., N.W., Washington, DC</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8316152</article-id>
              <article-id pub-id-type="pmcid">PMC8316152</article-id>
              <article-id pub-id-type="pmc-uid">8316152</article-id>
              <article-id pub-id-type="pmid">33753412</article-id>
              <article-id pub-id-type="pmid">33753412</article-id>
              <article-id pub-id-type="publisher-id">00026-21</article-id>
              <article-id pub-id-type="doi">10.1128/IAI.00026-21</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Host Response and Inflammation</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Lymphotoxin β Receptor: a Crucial Role in Innate and Adaptive Immune Responses against <named-content content-type="genus-species">Toxoplasma g</named-content><named-content content-type="genus-species">ondii</named-content></article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5193-2471</contrib-id>
                  <name>
                    <surname>Tersteegen</surname>
                    <given-names>Anne</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>a</sup>
                  </xref>
                  <xref rid="aff4" ref-type="aff">
                    <sup>d</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Sorg</surname>
                    <given-names>Ursula R.</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>a</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Virgen-Slane</surname>
                    <given-names>Richard</given-names>
                  </name>
                  <xref rid="aff2" ref-type="aff">
                    <sup>b</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Helle</surname>
                    <given-names>Marcel</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>a</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Petzsch</surname>
                    <given-names>Patrick</given-names>
                  </name>
                  <xref rid="aff3" ref-type="aff">
                    <sup>c</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Dunay</surname>
                    <given-names>Ildiko R.</given-names>
                  </name>
                  <xref rid="aff4" ref-type="aff">
                    <sup>d</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Köhrer</surname>
                    <given-names>Karl</given-names>
                  </name>
                  <xref rid="aff3" ref-type="aff">
                    <sup>c</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6281-0357</contrib-id>
                  <name>
                    <surname>Degrandi</surname>
                    <given-names>Daniel</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>a</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ware</surname>
                    <given-names>Carl F.</given-names>
                  </name>
                  <xref rid="aff2" ref-type="aff">
                    <sup>b</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5652-6330</contrib-id>
                  <name>
                    <surname>Pfeffer</surname>
                    <given-names>Klaus</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>a</sup>
                  </xref>
                  <email>klaus.pfeffer@hhu.de</email>
                </contrib>
                <aff id="aff1">
                  <label>a</label>
                  <addr-line>Institute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University, Düsseldorf, Germany</addr-line>
                </aff>
                <aff id="aff2">
                  <label>b</label>
                  <addr-line>Laboratory of Molecular Immunology, Infectious and Inflammatory Diseases Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA</addr-line>
                </aff>
                <aff id="aff3">
                  <label>c</label>
                  <addr-line>Biological and Medical Research Center (BMFZ), Heinrich Heine University, Düsseldorf, Germany</addr-line>
                </aff>
                <aff id="aff4">
                  <label>d</label>
                  <addr-line>Institute of Inflammation and Neurodegeneration, Otto-von-Guericke-University, Magdeburg, Germany</addr-line>
                </aff>
              </contrib-group>
              <contrib-group>
                <contrib contrib-type="editor">
                  <role>Editor</role>
                  <name>
                    <surname>Herbert</surname>
                    <given-names>De’Broski R.</given-names>
                  </name>
                  <aff>University of Pennsylvania</aff>
                </contrib>
              </contrib-group>
              <author-notes>
                <fn fn-type="other">
                  <p><bold>Citation</bold> Tersteegen A, Sorg UR, Virgen-Slane R, Helle M, Petzsch P, Dunay IR, Köhrer K, Degrandi D, Ware CF, Pfeffer K. 2021. Lymphotoxin β receptor: a crucial role in innate and adaptive immune responses against <italic toggle="yes">Toxoplasma gondii</italic>. Infect Immun 89:e00026-21. <ext-link xlink:href="https://doi.org/10.1128/IAI.00026-21" ext-link-type="uri">https://doi.org/10.1128/IAI.00026-21</ext-link>.</p>
                </fn>
              </author-notes>
              <pub-date publication-format="electronic" date-type="preprint">
                <day>22</day>
                <month>3</month>
                <year>2021</year>
              </pub-date>
              <pub-date publication-format="electronic" date-type="pub">
                <day>17</day>
                <month>5</month>
                <year>2021</year>
              </pub-date>
              <pub-date publication-format="electronic" date-type="collection">
                <month>6</month>
                <year>2021</year>
              </pub-date>
              <volume>89</volume>
              <issue>6</issue>
              <elocation-id>e00026-21</elocation-id>
              <history>
                <date date-type="received">
                  <day>15</day>
                  <month>1</month>
                  <year>2021</year>
                </date>
                <date date-type="rev-request">
                  <day>25</day>
                  <month>2</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>12</day>
                  <month>3</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>Copyright © 2021 Tersteegen et al.</copyright-statement>
                <copyright-year>2021</copyright-year>
                <copyright-holder>Tersteegen et al.</copyright-holder>
                <ali:free_to_read start_date="2021-05-17"/>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="iai.00026-21.pdf"/>
              <abstract>
                <title>ABSTRACT</title>
                <p>The lymphotoxin β receptor (LTβR) plays an essential role in the initiation of immune responses to intracellular pathogens. In mice, the LTβR is crucial for surviving acute toxoplasmosis; however, until now, a functional analysis was largely incomplete. Here, we demonstrate that the LTβR is a key regulator required for the intricate balance of adaptive immune responses. <named-content content-type="genus-species">Toxoplasma gondii</named-content>-infected LTβR-deficient (LTβR<sup>−/−</sup>) mice show globally altered interferon-γ (IFN-γ) regulation, reduced IFN-γ-controlled host effector molecule expression, impaired T cell functionality, and an absent anti-parasite-specific IgG response, resulting in a severe loss of immune control of the parasites. Reconstitution of LTβR<sup>−/−</sup> mice with toxoplasma immune serum significantly prolongs survival following <named-content content-type="genus-species">T. gondii</named-content> infection. Notably, analysis of RNA-seq data clearly indicates a specific effect of <named-content content-type="genus-species">T. gondii</named-content> infection on the B cell response and isotype switching. This study uncovers the decisive role of the LTβR in cytokine regulation and adaptive immune responses to control <named-content content-type="genus-species">T. gondii</named-content>.</p>
              </abstract>
              <kwd-group>
                <title>KEYWORDS</title>
                <kwd>lymphotoxin</kwd>
                <kwd>
                  <italic toggle="yes">Toxoplasma gondii</italic>
                </kwd>
                <kwd>host-pathogen interactions</kwd>
              </kwd-group>
              <funding-group specific-use="FundRef">
                <award-group award-type="grant" id="award1">
                  <funding-source id="GS1">
                    <institution-wrap>
                      <institution>Juergen Manchot Foundation</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>Molecules of Infetion III</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Pfeffer</surname>
                      <given-names>Klaus</given-names>
                    </name>
                  </principal-award-recipient>
                  <principal-award-recipient>
                    <name>
                      <surname>Degrandi</surname>
                      <given-names>Daniel</given-names>
                    </name>
                  </principal-award-recipient>
                  <principal-award-recipient>
                    <name>
                      <surname>Tersteegen</surname>
                      <given-names>Anne Kathrin</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
              </funding-group>
              <funding-group specific-use="FundRef">
                <award-group award-type="grant" id="award2">
                  <funding-source id="GS2">
                    <institution-wrap>
                      <institution>Perkins Family Foundation</institution>
                    </institution-wrap>
                  </funding-source>
                  <principal-award-recipient>
                    <name>
                      <surname>Ware</surname>
                      <given-names>Carl F.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
              </funding-group>
              <funding-group specific-use="FundRef">
                <award-group award-type="grant" id="award3">
                  <funding-source id="GS3">
                    <institution-wrap>
                      <institution>Perkins Family Foundation fellowship</institution>
                    </institution-wrap>
                  </funding-source>
                  <principal-award-recipient>
                    <name>
                      <surname>Virgen-Slane</surname>
                      <given-names>Richard</given-names>
                    </name>
                  </principal-award-recipient>
                  <principal-award-recipient>
                    <name>
                      <surname>Ware</surname>
                      <given-names>Carl F.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
              </funding-group>
              <funding-group specific-use="FundRef">
                <award-group award-type="grant" id="award4">
                  <funding-source id="GS4">
                    <institution-wrap>
                      <institution>NIH</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>R01AI158552</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Ware</surname>
                      <given-names>Carl F.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
              </funding-group>
              <counts>
                <fig-count count="7"/>
                <table-count count="0"/>
                <equation-count count="0"/>
                <ref-count count="75"/>
                <page-count count="20"/>
                <word-count count="11889"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>June 2021</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec sec-type="intro" id="s1">
              <title>INTRODUCTION</title>
              <p>The lymphotoxin β receptor (LTβR) is one of the core members of the tumor necrosis factor (TNF)/TNF receptor (TNFR) superfamily (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>). It has two cognate ligands, LTβ (LTα<sub>1</sub>β<sub>2</sub>) and LIGHT (homologous to lymphotoxins, exhibits inducible expression, and competes with herpesvirus [HSV] glycoprotein D for herpesvirus entry mediator [HVEM], a receptor expressed by T lymphocytes) (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>). LTβR-mediated signaling is known to be essential for the organogenesis of secondary lymphoid tissues, the maintenance of their structure, and its role in mediating innate immune responses to many pathogens is also well documented (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B5" ref-type="bibr">5</xref><xref rid="B6" ref-type="bibr">–</xref><xref rid="B7" ref-type="bibr">7</xref>). LTβR-deficient (LTβR<sup>−/−</sup>) mice lack lymph nodes (LNs) and Peyer’s patches (PPs), show reduced numbers of natural killer (NK) cells and dendritic cells (DCs) as well as impaired immunoglobulin (Ig) affinity maturation (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>). In infection models, LTβR<sup>−/−</sup> mice show pronounced defects in their immune response against <named-content content-type="genus-species">Listeria monocytogenes</named-content>, <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> (<xref rid="B5" ref-type="bibr">5</xref>), cytomegalovirus (<xref rid="B9" ref-type="bibr">9</xref>), lymphocytic choriomeningitis virus (LCMV) (<xref rid="B10" ref-type="bibr">10</xref>), and Zika virus (<xref rid="B11" ref-type="bibr">11</xref>), as well as <named-content content-type="genus-species">Toxoplasma gondii</named-content> (<italic toggle="yes">T. gondii</italic>) (<xref rid="B12" ref-type="bibr">12</xref>). In spite of these extensive deficits, not much is known about the exact role of LTβR signaling for efficient generation of the immune response against pathogens.</p>
              <p><named-content content-type="genus-species">T. gondii</named-content>, the causative agent of toxoplasmosis, is an obligate intracellular parasite belonging to the Apicomplexa. It is able to invade most warm-blooded vertebrates, including humans (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B14" ref-type="bibr">14</xref>), and can infect all nucleated cells. While acute toxoplasmosis usually presents with only mild, flu-like symptoms in immunocompetent hosts, it sometimes manifests as lymphadenitis, hepatosplenomegaly, myocarditis, or pneumonia. In immunocompromised patients, toxoplasmosis can cause serious health problems and, when primary infection occurs during pregnancy, severe congenital defects may occur (<xref rid="B15" ref-type="bibr">15</xref><xref rid="B16" ref-type="bibr">–</xref><xref rid="B17" ref-type="bibr">17</xref>).</p>
              <p>The early immune response to <named-content content-type="genus-species">T. gondii</named-content> is characterized by recognition of <named-content content-type="genus-species">T. gondii</named-content>-associated molecules (i.e., profilin) by different cell types, such as DCs. These cells produce distinct cytokines in response to infection, such as interleukin-12 (IL-12) and TNF, thus activating and stimulating other cell types, including NK cells (<xref rid="B18" ref-type="bibr">18</xref>), T cells (<xref rid="B19" ref-type="bibr">19</xref>), innate lymphoid cells (ILCs) (<xref rid="B20" ref-type="bibr">20</xref>), and macrophages (<xref rid="B21" ref-type="bibr">21</xref>), which in turn, produce inflammatory cytokines such as IFN-γ.</p>
              <p>IFN-γ signaling is essential for limiting <named-content content-type="genus-species">T. gondii</named-content> proliferation during the acute stage of toxoplasmosis and driving the parasite into the chronic stage, where it is contained by a functional immune response (<xref rid="B22" ref-type="bibr">22</xref><xref rid="B23" ref-type="bibr">–</xref><xref rid="B25" ref-type="bibr">25</xref>). IFN-γ-driven effector mechanisms include induction of cell-autonomous effector mechanisms (<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B27" ref-type="bibr">27</xref>), such as depletion of tryptophan (<xref rid="B28" ref-type="bibr">28</xref>) and reactive nitrogen production (<xref rid="B29" ref-type="bibr">29</xref>), which suppress <named-content content-type="genus-species">T. gondii</named-content> replication and are essential for restricting parasite growth. IFN-γ also strongly induces murine guanylate-binding proteins (mGBPs), which play a major role in restricting parasite growth of <named-content content-type="genus-species">T. gondii</named-content> as well as other intracellular pathogens (<xref rid="B30" ref-type="bibr">30</xref><xref rid="B31" ref-type="bibr">–</xref><xref rid="B33" ref-type="bibr">33</xref>). Within an infected cell, <named-content content-type="genus-species">T. gondii</named-content> resides within a parasitophorous vacuole (PV) that effectively protects the parasite from lysosomal activity (<xref rid="B34" ref-type="bibr">34</xref>). mGBPs are recruited to the PV and are instrumental in destroying first the PV and then the parasites within (<xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B36" ref-type="bibr">36</xref>).</p>
              <p>Previous studies have shown that other core members of the TNF/TNFR superfamily, such as the ligands TNF and LTα, which signal via the TNFRI receptor, also play an important part in the immune response to <named-content content-type="genus-species">T. gondii</named-content> (<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B38" ref-type="bibr">38</xref>). However, there is only limited data published on the role of the LTβR; it has been demonstrated that signaling via the LTβR is essential for the upregulation of mGBPs after <named-content content-type="genus-species">T. gondii</named-content> infection as well as for overall survival (<xref rid="B12" ref-type="bibr">12</xref>). Glatman Zaretsky et al. have shown that LTβ signaling is important for maintaining intact splenic architecture and, indirectly, for efficient <named-content content-type="genus-species">T. gondii</named-content>-specific antibody production in <named-content content-type="genus-species">T. gondii</named-content> type II strains (Prugniaud) (<xref rid="B39" ref-type="bibr">39</xref>). Nevertheless, the pathophysiology responsible for the increased susceptibility of LTβR<sup>−/−</sup> mice to <named-content content-type="genus-species">T. gondii</named-content> infection is still elusive.</p>
              <p>Here, we demonstrate that LTβR deficiency results in dramatically dysregulated IFN-γ responses, impaired expression of antiparasite effector molecules, limited T cell functionality, and an abrogated <named-content content-type="genus-species">T. gondii</named-content> specific IgG response. We show that by transfer of <named-content content-type="genus-species">T. gondii</named-content> immune serum, survival of LTβR<sup>−/−</sup> mice can be prolonged, demonstrating that the susceptibility of LTβR<sup>−/−</sup> mice to <named-content content-type="genus-species">T. gondii</named-content> infection is possibly due to a direct role of LTβR signaling in Ig class switch. These results lead to a new understanding of LTβR-mediated immunity and the pathophysiology of toxoplasmosis and will hopefully aid in developing much-needed new treatment and prevention options such as passive vaccination strategies for human toxoplasmosis.</p>
            </sec>
            <sec sec-type="results" id="s2">
              <title>RESULTS</title>
              <sec id="s2-1">
                <title>LTβR deficiency leads to increased parasite burden in lung, spleen, and muscle.</title>
                <p>While wild-type C57BL/6 (WT) mice survive a <named-content content-type="genus-species">T. gondii</named-content> infection, LTβR<sup>−/−</sup> mice are highly susceptible to <named-content content-type="genus-species">T. gondii</named-content> infection and do not survive beyond day 14 postinfection (p.i.) (<xref rid="F1" ref-type="fig">Fig. 1a</xref>). This high susceptibility is in accordance with our previous study (<xref rid="B12" ref-type="bibr">12</xref>). To characterize the cause of this susceptibility in LTβR<sup>−/−</sup> mice, we first assessed the parasite burden in <named-content content-type="genus-species">T. gondii</named-content>-infected WT and LTβR<sup>−/−</sup> animals during the acute phase of infection via quantitative realtime PCR (qRT-PCR) (<xref rid="F1" ref-type="fig">Fig. 1b</xref>). In lung tissue, we found increasing amounts of <named-content content-type="genus-species">T. gondii</named-content> DNA up to day 10 p.i. in both cohorts, with significantly larger amounts in LTβR<sup>−/−</sup> than WT mice on day 10 p.i. In the spleen, <named-content content-type="genus-species">T. gondii</named-content> DNA amounts increased only moderately in WT mice through the course of infection (<xref rid="F1" ref-type="fig">Fig. 1b</xref>). In contrast, LTβR<sup>−/−</sup> mice showed a significant increase of <named-content content-type="genus-species">T. gondii</named-content> DNA by day 10 p.i. and significantly increased amounts compared to WT mice on days 7 and 10 p.i. Interestingly, in both genotypes, reduced amounts of <named-content content-type="genus-species">T. gondii</named-content> DNA were detected on day 10 compared to day 7 p.i. Similar results were observed in muscle tissue (<xref rid="F1" ref-type="fig">Fig. 1b</xref>). In WT mice, the parasite burden rose only moderately, while LTβR<sup>−/−</sup> mice showed a significant increase by day 10 p.i. as well as significantly larger amounts on days 7 and 10 p.i. To summarize, LTβR<sup>−/−</sup> mice showed increased parasite burden compared to WT mice, pointing toward a failure of these animals to adequately control parasite proliferation in the acute phase of infection.</p>
                <fig position="float" id="F1">
                  <label>FIG 1</label>
                  <caption>
                    <p>LTβR<sup>−/−</sup> mice show increased parasite load and dysregulated cytokine expression. (a) Survival of <named-content content-type="genus-species">T. gondii</named-content>-infected (ME49, 40 cysts, i.p.) WT (<italic toggle="yes">n</italic> = 15) and LTβR<sup>−/−</sup> (<italic toggle="yes">n</italic> = 13) mice. (b) qRT-PCR analysis of <named-content content-type="genus-species">T. gondii</named-content> DNA (assessing parasite load) in lung, spleen, and muscle tissue of uninfected (d0) and <named-content content-type="genus-species">T. gondii</named-content>-infected WT and LTβR<sup>−/−</sup> mice (d0 to d7, <italic toggle="yes">n</italic> ≥ 12; d10, <italic toggle="yes">n</italic> ≥ 14). (c) Expression of IFN-γ, TNF-α, IL-6, IL-10, and CCL2 in the serum of uninfected and <named-content content-type="genus-species">T. gondii</named-content>-infected WT and LTβR<sup>−/−</sup> mice (d0 to d7, <italic toggle="yes">n</italic> ≥ 12; d10, <italic toggle="yes">n</italic> = 18) analyzed via bead-based immunoassay. The data shown represent at least three independent experiments; symbols represent individual animals, columns represent mean values, and error bars represent the ± SEM. A log rank (Mantel Cox) test was used for statistical analysis represented in panel a. Two-way ANOVA corrected for multiple comparison using Tukey’s <italic toggle="yes">post hoc</italic> test was used for the statistical analysis represented in panels b and c. *, <italic toggle="yes">P</italic> &lt; 0.0332; **, <italic toggle="yes">P</italic> &lt; 0.0021; ***, <italic toggle="yes">P</italic> &lt; 0.0002; ****, <italic toggle="yes">P</italic> &lt; 0.0001.</p>
                  </caption>
                  <graphic xlink:href="iai.00026-21-f001" position="float"/>
                </fig>
              </sec>
              <sec id="s2-2">
                <title>Dysregulated cytokines in the serum of LTβR<sup>−/−</sup> mice after infection with <named-content content-type="genus-species">T. gondii</named-content>.</title>
                <p>Since cytokines, especially IFN-γ and TNF-α, as signature molecules of a Th1 response play an important role in containing <named-content content-type="genus-species">T. gondii</named-content> expansion (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B40" ref-type="bibr">40</xref>), we analyzed cytokine amounts in sera of infected mice (<xref rid="F1" ref-type="fig">Fig. 1c</xref>). In both genotypes IFN-γ amounts increased slightly by day 4 p.i. In WT animals, IFN-γ amounts increased significantly by day 7 p.i. but were found to be markedly decreased again on day 10 p.i. While LTβR<sup>−/−</sup> mice also showed a significant increase of IFN-γ expression on day 7 p.i., amounts were significantly lower than those of WT animals. Also, in LTβR<sup>−/−</sup> mice, IFN-γ expression levels were <strike>s</strike>ignificantly higher on day 10 p.i. than those of WT animals. TNF-α expression increased significantly in WT as well as LTβR<sup>−/−</sup> animals by day 10 p.i. and did not differ significantly between the two genotypes, although amounts in LTβR<sup>−/−</sup> mice seemed to rise more steeply later in infection (day 7 versus day 10 p.i. for WT and LTβR<sup>−/−</sup> mice, respectively).</p>
                <p>In WT animals, expression of IL-6, another proinflammatory cytokine (<xref rid="B41" ref-type="bibr">41</xref>), was slightly increased on day 4 and day 7 p.i. but was reduced again on day 10 p.i. (<xref rid="F1" ref-type="fig">Fig. 1c</xref>). In contrast, in LTβR<sup>−/−</sup> mice, IL-6 amounts rose significantly during the course of infection and were significantly higher on days 7 and 10 p.i. than those of WT mice. Amounts of IL-10, known for its anti-inflammatory properties during infection (<xref rid="B42" ref-type="bibr">42</xref>), did not change significantly in WT animals during the course of infection (<xref rid="F1" ref-type="fig">Fig. 1c</xref>). In contrast, amounts in LTβR<sup>−/−</sup> animals rose significantly on day 10 p.i. and were significantly higher than those of WT mice. The monocyte chemotactic factor (CCL2), a chemokine described to be induced by <named-content content-type="genus-species">T. gondii</named-content> (<xref rid="B43" ref-type="bibr">43</xref>), increased in WT as well as LTβR<sup>−/−</sup> mice on days 4 and 7 p.i. But while CCL2 in WT mice declined again by day 10 p.i., CCL2 further increased in LTβR<sup>−/−</sup> mice on day 10 p.i. and was significantly higher than in WT mice (<xref rid="F1" ref-type="fig">Fig. 1c</xref>). Interestingly, LTβR<sup>−/−</sup> mice showed increased baseline amounts (day 0) for IFN-γ, TNF-α, IL-6, and CCL2 compared to WT mice, even though these differences were not significant.</p>
                <p>Significantly different amounts were detected for IFN-β, IL-1α, IL-23, and IL-27 only on day 4 p.i. (see Fig. S1 in the supplemental material). LTβR<sup>−/−</sup> animals showed increased baseline amounts (day 0) for IFN-β, IL-1α, IL-1β, IL-17A, IL-23, IL-27, and IL-12p70, which were, however, significant only in the case of IL-1β. No differences in IL-12p70 levels were detected for the two genotypes (Fig. S1).</p>
                <p>To summarize, uninfected LTβR<sup>−/−</sup> mice show different baseline amounts of proinflammatory cytokines, suggesting a subtle activation of the immune system. Furthermore, in these animals, the coordinated immune defense during <named-content content-type="genus-species">T. gondii</named-content> infection is dysregulated.</p>
              </sec>
              <sec id="s2-3">
                <title>Markedly altered transcriptome in the lungs of LTβR<sup>−/−</sup> mice after <named-content content-type="genus-species">T. gondii</named-content> infection.</title>
                <p>The lungs are one of the target organs of <named-content content-type="genus-species">T. gondii</named-content> tachyzoite dissemination (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B44" ref-type="bibr">44</xref>). In line with that observation, we detected large amounts of <named-content content-type="genus-species">T. gondii</named-content> DNA in lung tissue of LTβR<sup>−/−</sup> compared to WT mice on day 4 p.i. (<xref rid="F1" ref-type="fig">Fig. 1b</xref>). To determine whether WT and LTβR<sup>−/−</sup> mice show differences in global gene expression patterns in the lungs, we analyzed lung tissue via transcriptome sequencing (RNA-seq) on day 7 p.i. Interestingly, gene set enrichment analysis (GSEA) of these data showed a significant upregulation of Gene Ontology (GO) (biological process) molecular signatures for “response to type I interferons, response to interferon gamma, and interferon gamma mediated signaling pathway” in <named-content content-type="genus-species">T. gondii</named-content>-infected WT compared to LTβR<sup>−/−</sup> mice on day 7 p.i. (Fig. S2). The data depicted by a volcano plot (<xref rid="F2" ref-type="fig">Fig. 2a</xref>) clearly show a significant upregulation of IFN-γ-regulated genes in <named-content content-type="genus-species">T. gondii</named-content>-infected WT mice compared to LTβR<sup>−/−</sup> mice (day 7 p.i.); for instance, transcripts for mGBPs (mGBP2b/1, 2, 6, 7, and 10), transcripts for effector molecules (IDO1, Gzmk), transcripts for chemokines and chemokine receptors responsible for recruitment of immune cells (CCL2, CCL4, CCL7, CXCL9, CXCL10, CCR1), transcripts for proteins involved in IFN-γ signaling (IRF1, STAT1), transcripts induced by IFN-γ (TGTP1, PIM1), and other transcripts known to be involved in immune responses (CD274, IL12Rb1, Ly6i, Ly6c2, MMP8, RNF19b) were found to be highly expressed in infected WT but not in LTβR<sup>−/−</sup> lungs on day 7 p.i. This suggests that LTβR<sup>−/−</sup> mice fail to adequately upregulate (IFN-γ-dependent) immune responses in the lung.</p>
                <fig position="float" id="F2">
                  <label>FIG 2</label>
                  <caption>
                    <p>Lungs of LTβR<sup>−/−</sup> mice show an altered transcriptome after <named-content content-type="genus-species">T. gondii</named-content> infection. (a) Volcano plot showing RNA-seq data of lung tissue of infected WT mice correlated with infected LTβR<sup>−/−</sup> mice (d7 p.i.; <italic toggle="yes">n</italic> = 3/group). The dashed horizontal black line represents an adjusted <italic toggle="yes">P</italic> value of 0.1 (Wald test). (b and c) qRT-PCR analysis of (b) cytokines (IFN-γ and TNF-α) and (c) host effector molecules (iNOS, IDO1, NOX2-gp91phox) in lung tissue from uninfected (d0) and <named-content content-type="genus-species">T. gondii</named-content>-infected (ME49, 40 cysts, i.p.) WT and LTβR<sup>−/−</sup> mice (d0 to 7, <italic toggle="yes">n</italic> ≥ 12; d10, <italic toggle="yes">n</italic> ≥ 14; exception: IFN-γ, <italic toggle="yes">n</italic> ≥ 3, d0 to 10 p.i.). Data shown in panels b and c represent four independent experiments; symbols represent individual animals, columns represent mean values, and error bars represent the ± SEM. Two-way ANOVA corrected for multiple comparison using Tukey’s <italic toggle="yes">post hoc</italic> test was used for the statistical analysis. *, <italic toggle="yes">P</italic> &lt; 0.0332; **, <italic toggle="yes">P</italic> &lt; 0.0021; ***, <italic toggle="yes">P</italic> &lt; 0.0002; ****, <italic toggle="yes">P</italic> &lt; 0.0001.</p>
                  </caption>
                  <graphic xlink:href="iai.00026-21-f002" position="float"/>
                </fig>
              </sec>
              <sec id="s2-4">
                <title>LTβR deficiency leads to dysregulation of cytokine expression in the lung.</title>
                <p>To add additional kinetic data RNA-seq data (<xref rid="F2" ref-type="fig">Fig. 2a</xref>) and cytokine levels in serum (<xref rid="F1" ref-type="fig">Fig. 1c</xref>; Fig. S1), we determined mRNA expression levels of cytokines in the lungs of infected WT and LTβR<sup>−/−</sup> mice at several time points after infection (<xref rid="F2" ref-type="fig">Fig. 2b</xref> and <xref rid="F2" ref-type="fig">c</xref>). Baseline expression levels of IFN-γ were higher in LTβR<sup>−/−</sup> animals; thus, while levels rose on day 4 p.i. in both genotypes, this increase was only significant in WT mice (<xref rid="F2" ref-type="fig">Fig. 2b</xref>). While IFN-γ mRNA levels were markedly decreased in WT mice by day 10 p.i., they were still markedly but not significantly elevated in LTβR<sup>−/−</sup> mice (<xref rid="F2" ref-type="fig">Fig. 2b</xref>). Baseline expression of TNF-α was increased in LTβR<sup>−/−</sup> mice but did not change significantly during the course of infection. WT mice showed a significant increase in TNF-α expression on day 10 p.i. (<xref rid="F2" ref-type="fig">Fig. 2b</xref>), indicating a significant difference in the cytokine response between the two genotypes on day 10 p.i. Baseline expression levels of LTβ were significantly increased in LTβR<sup>−/−</sup> mice, which could be due to a lack of negative feedback or compensatory mechanisms. However, while levels tended to be higher in LTβR<sup>−/−</sup> animals throughout the infection, there were no significant differences in LTβ expression between the two genotypes (Fig. S3). IL-4 expression was significantly increased in WT animals on day 10 p.i. compared to baseline expression. In LTβR<sup>−/−</sup> mice, IL-4 expression was comparable to that of WT mice but not significantly increased on day 10 p.i. compared to baseline expression (Fig. S3). These data confirm that LTβR<sup>−/−</sup> mice show a dysregulated immune homeostasis not only in serum (<xref rid="F1" ref-type="fig">Fig. 1c</xref>; Fig. S1) but also in lung tissue after <named-content content-type="genus-species">T. gondii</named-content> infection.</p>
              </sec>
              <sec id="s2-5">
                <title>LTβR deficiency leads to impaired IFN-γ-regulated effector molecule expression in the lung.</title>
                <p>IFN-γ-regulated effector molecules are pivotal in <named-content content-type="genus-species">T. gondii</named-content> elimination (<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B45" ref-type="bibr">45</xref>), having important immune response functions. In particular, the roles of effector molecules, such as iNOS, IDO, and NOX2-gp91phox (<xref rid="B46" ref-type="bibr">46</xref><xref rid="B47" ref-type="bibr">–</xref><xref rid="B48" ref-type="bibr">48</xref>), are well documented. Since RNA-seq data (<xref rid="F2" ref-type="fig">Fig. 2a</xref>) showed high expression of effector molecules in infected WT, but not LTβR<sup>−/−</sup> (<xref rid="B31" ref-type="bibr">31</xref>) mice we assessed the expression of major effector molecules in lungs by qRT-PCR next (<xref rid="F2" ref-type="fig">Fig. 2c</xref>). In contrast to WT mice, LTβR<sup>−/−</sup> mice failed to upregulate iNOS expression postinfection, leading to significant differences between the two genotypes on days 7 and 10 p.i. WT mice showed significant upregulation of IDO1 expression on day 4 p.i. and had significantly increased IDO1 expression levels on day 10 p.i., whereas LTβR<sup>−/−</sup> mice showed only a minor increase of IDO1 expression, and this difference was not significant compared to baseline expression. NOX2-gp91phox presented a similar picture—significantly increased NOX2-gp91phox expression in WT animals on day 10 p.i. compared to baseline expression as well as compared to LTβR<sup>−/−</sup> mice and a complete failure of upregulation of NOX2-gp91phox in the absence of LTβR. The failure to adequately upregulate IFN-γ-regulated effector molecules involved in cell intrinsic defense mechanisms essential for suppressing <named-content content-type="genus-species">T. gondii</named-content> replication most likely contributes to the increased parasite burden observed in LTβR<sup>−/−</sup> animals.</p>
              </sec>
              <sec id="s2-6">
                <title>LTβR deficiency leads to impaired IFN-γ-induced mGBP expression and IFN-γ signaling in the lung.</title>
                <p>Another important group of genes upregulated in an IFN-γ-dependent manner after <named-content content-type="genus-species">T. gondii</named-content> infection are mGBPs (<xref rid="B30" ref-type="bibr">30</xref>). These GTPases have been shown to be essentially involved in <named-content content-type="genus-species">T. gondii</named-content> elimination (<xref rid="B30" ref-type="bibr">30</xref><xref rid="B31" ref-type="bibr">–</xref><xref rid="B33" ref-type="bibr">33</xref>). A heat map for mGBP expression data (<xref rid="F3" ref-type="fig">Fig. 3a</xref>) was generated from the RNA-seq data, illustrating an overall slight increase in baseline mGBP expression in uninfected (day 0) LTβR<sup>−/−</sup> mice compared to WT mice but an overall lower mGBP expression in LTβR<sup>−/−</sup> compared to WT mice on day 7 p.i. These results were confirmed by qRT-PCR analysis of mGBP mRNA expression; for all mGBPs analyzed (mGBP1, 2, 3, 5, 6/10, 7, 8, and 9), we observed a significant increase in mGBP expression (<italic toggle="yes">P</italic> &lt; 0.0001 in all cases) in WT animals by day 10 p.i. (<xref rid="F3" ref-type="fig">Fig. 3b</xref>). In contrast, in LTβR<sup>−/−</sup> mice, a significant rise on day 10 p.i. compared to baseline expression was only observed for mGBP2, mGBP3, and mGBP7. Also, expression levels of all mGBPs were significantly higher in WT mice than in to LTβR<sup>−/−</sup> mice on day 10 p.i., with the exception of mGBP6/10, where expression levels were only slightly increased in WT mice. The failure to adequately upregulate expression of mGBPs early after <named-content content-type="genus-species">T. gondii</named-content> infection was further confirmed by immunoblot analysis, where upregulation of mGBP2 and mGBP7 protein expression was already detectable on day 4 p.i. in WT mice but not in LTβR<sup>−/−</sup> mice (<xref rid="F3" ref-type="fig">Fig. 3c</xref>; Fig. S4). This defect in upregulation of mGBP expression after <named-content content-type="genus-species">T. gondii</named-content> expression likely has a major effect on the ability of LTβR<sup>−/−</sup> mice to contain parasite replication, as mGBPs are essential for an effective immune response against this parasite (<xref rid="B31" ref-type="bibr">31</xref><xref rid="B32" ref-type="bibr">–</xref><xref rid="B33" ref-type="bibr">33</xref>).</p>
                <fig position="float" id="F3">
                  <label>FIG 3</label>
                  <caption>
                    <p>LTβR deficiency dysregulates IFN-γ signaling in the lung. (a) Heat map of differentially expressed murine guanylate-binding proteins (mGBPs) based on RNA-seq analysis (Wald test and adjusted <italic toggle="yes">P</italic> value of 0.1) of lung tissue from uninfected (d0) and <named-content content-type="genus-species">T. gondii</named-content>-infected (ME49, 40 cysts i.p., d7 p.i.) WT and LTβR<sup>−/−</sup> mice (<italic toggle="yes">n</italic> = 3). (b) qRT-PCR of mGBPs in lung tissue from uninfected and <named-content content-type="genus-species">T. gondii</named-content>-infected WT and LTβR<sup>−/−</sup> mice (d0 to 7, <italic toggle="yes">n</italic> ≥ 12; d10, <italic toggle="yes">n</italic> ≥ 14). The data shown represent four independent experiments; symbols represent individual animals, columns represent mean values, and error bars represent the ± SEM. (c) Immunoblot analysis of proteins involved in or induced via the IFN-γ signaling pathway in lung tissue from uninfected and <named-content content-type="genus-species">T. gondii</named-content>-infected WT and LTβR<sup>−/−</sup> mice. Two-way ANOVA corrected for multiple comparison using Tukey’s <italic toggle="yes">post hoc</italic> test was used for the statistical analysis represented in panel b. *, <italic toggle="yes">P</italic> &lt; 0.0332; **, <italic toggle="yes">P</italic> &lt; 0.0021; ***, <italic toggle="yes">P</italic> &lt; 0.0002; ****, <italic toggle="yes">P</italic> &lt; 0.0001. The data shown in panel c are representative of three independent experiments.</p>
                  </caption>
                  <graphic xlink:href="iai.00026-21-f003" position="float"/>
                </fig>
                <p>Since protein expression of IFN-γ-induced mGBPs was affected in lungs of LTβR<sup>−/−</sup> mice in <named-content content-type="genus-species">T. gondii</named-content> infection, we further analyzed protein expression of prototype genes directly involved in IFN-γR signaling (<xref rid="F3" ref-type="fig">Fig. 3c</xref>; Fig. S4). Protein expression levels of STAT1, pSTAT1, IRF-1, and pSTAT3 increased in WT mice during the course of infection. In contrast, LTβR<sup>−/−</sup> animals showed a marked delay in the upregulation of these proteins. In WT animals, JAK1 and STAT3 expression increased until day 7 p.i. but decreased again on day 10 p.i. In uninfected LTβR<sup>−/−</sup> mice, expression of these proteins was higher than in uninfected WT mice but did not increase early in infection. This also provides evidence for an altered IFN-γ/IFN-γR signaling axis during <named-content content-type="genus-species">T. gondii</named-content> infection.</p>
                <p>To summarize, mRNA and protein expression data from the lungs indicate that uninfected LTβR<sup>−/−</sup> animals show an activated immune status compared to WT animals but fail to adequately upregulate IFN-γ-dependent immune effector responses after <named-content content-type="genus-species">T. gondii</named-content> infection, possibly explaining the increased parasite burden and the subsequently increased infection susceptibility of LTβR<sup>−/−</sup> mice.</p>
              </sec>
              <sec id="s2-7">
                <title>mGBP upregulation and recruitment to the PV after IFN-γ stimulation <italic toggle="yes">in vitro</italic>.</title>
                <p>Since upregulation of mGBP expression was impaired in LTβR<sup>−/−</sup> mice after <named-content content-type="genus-species">T. gondii</named-content> infection (<xref rid="F3" ref-type="fig">Fig. 3</xref>), we asked whether IFN-γ-dependent upregulation of mGBP expression was directly dependent on LTβR signaling (<xref rid="F4" ref-type="fig">Fig. 4</xref>). We therefore analyzed whether LTβR<sup>−/−</sup> mouse embryonic fibroblasts (MEFs) were able to upregulate mGBPs after IFN-γ stimulation and whether mGBPs could recruit to the PV in infected, IFN-γ-pretreated LTβR<sup>−/−</sup> MEFs. After preincubation with IFN-γ <italic toggle="yes">in vitro</italic>, <named-content content-type="genus-species">T. gondii</named-content>-infected LTβR<sup>−/−</sup> and WT MEFs showed comparable upregulation of all tested mGBPs (mGBP1, 2, 3, 5, 6/10, 7, and 9), with the exception of mGBP8, where WT mice showed increased mRNA expression (<xref rid="F4" ref-type="fig">Fig. 4a</xref>). Also, after preincubation with IFN-γ, mGBP2 was recruited to the PV of <named-content content-type="genus-species">T. gondii</named-content> in LTβR<sup>−/−</sup> MEFs (<xref rid="F4" ref-type="fig">Fig. 4b</xref>). These results demonstrate that expression of mGBPs can be successfully induced in LTβR<sup>−/−</sup> MEFs in the presence of exogenous IFN-γ and that the lack of LTβR signaling appears not to interfere with the ability of mGBP2 to recruit to the PV in LTβR<sup>−/−</sup> MEFs. This suggests that the absence of LTβR signals do not impact IFN-γR signaling required for mGBP function.</p>
                <fig position="float" id="F4">
                  <label>FIG 4</label>
                  <caption>
                    <p>mGBP upregulation and recruitment. (a) qRT-PCR analysis of mGBP mRNA expression of uninfected WT and LTβR<sup>−/−</sup> MEFs stimulated with IFN-γ (7.5 ng/ml) for 8 h (all <italic toggle="yes">n</italic> = 3, except for mGBP1, where <italic toggle="yes">n</italic> = 2). Each symbol represents an individual technical replicate; columns represent mean values, and error bars represent the ± SEM. two-way ANOVA corrected for multiple comparisons by the Sidak <italic toggle="yes">post hoc</italic> test was used for statistical analysis. *, <italic toggle="yes">P</italic> &lt; 0.00332. (b) Representative immunofluorescence analysis of <named-content content-type="genus-species">T. gondii</named-content> tachyzoite-infected (multiplicity of infection [MOI], 1:40) WT and LTβR<sup>−/−</sup> MEFs. Cells were prestimulated with IFN-γ (7.5 ng/ml) for 16 h before being infected with <named-content content-type="genus-species">T. gondii</named-content> tachyzoites for 2 h. <named-content content-type="genus-species">T. gondii</named-content> surface antigen SAG1 was visualized using a Cy3-conjugated secondary antibody, and mGBP2 was visualized using an mGBP2 antiserum (30) followed by an Alexa Fluor 633-conjugated secondary antibody for detection of mGBP2 recruitment toward the <named-content content-type="genus-species">T. gondii</named-content> PV. Cell nuclei were stained using DAPI (4′,6-diamidino-2-phenylindole). The data shown in panels a and b represent at least two independent experiments.</p>
                  </caption>
                  <graphic xlink:href="iai.00026-21-f004" position="float"/>
                </fig>
              </sec>
              <sec id="s2-8">
                <title>Differences in spleen size and weight in LTβR<sup>−/−</sup> mice.</title>
                <p>Since LTβR<sup>−/−</sup> mice lack lymph nodes (<xref rid="B7" ref-type="bibr">7</xref>), the spleen is the primary organ where the immune response against <named-content content-type="genus-species">T. gondii</named-content> is primed. It has been described that during the acute phase of <named-content content-type="genus-species">T. gondii</named-content> infection, the splenic architecture is disrupted transiently (<xref rid="B39" ref-type="bibr">39</xref>). When we compared spleens of WT versus LTβR<sup>−/−</sup> mice, spleens of the latter were markedly larger (Fig. S5a) in uninfected (day 0) healthy animals. While spleens of both genotypes significantly increased in weight during the course of <named-content content-type="genus-species">T. gondii</named-content> infection, spleen weights of WT mice were significantly higher than those of LTβR<sup>−/−</sup> mice on day 10 p.i. (Fig. S5b). This increase of spleen weight in WT mice was not due to increased cellularity, as splenocyte counts were consistently higher in LTβR<sup>−/−</sup> spleens before as well as on days 4 and 7 p.i. (Fig. S5c). By day 10 p.i., cell numbers in the spleens of both genotypes were comparable, mostly due to a significant drop of splenocyte numbers in LTβR<sup>−/−</sup> mice. This also indicates that the initial immune response in spleens of LTβR<sup>−/−</sup> mice is disturbed.</p>
              </sec>
              <sec id="s2-9">
                <title>No apparent difference in T cell subpopulations in spleens of LTβR<sup>−/−</sup> mice.</title>
                <p>Accordingly, we analyzed the composition of the splenocytes using flow cytometry (<xref rid="F5" ref-type="fig">Fig. 5</xref>). Since T cells are essential to control <named-content content-type="genus-species">T. gondii</named-content> infection (<xref rid="B49" ref-type="bibr">49</xref>, <xref rid="B50" ref-type="bibr">50</xref>), we analyzed T cell subpopulations in LTβR<sup>−/−</sup> spleens (<xref rid="F5" ref-type="fig">Fig. 5a</xref>). Analysis of absolute numbers of CD3<sup>+</sup>, CD4<sup>+</sup>, CD8<sup>+</sup>, activated (CD3<sup>+</sup>CD25<sup>+</sup>) T cells, and <named-content content-type="genus-species">T. gondii</named-content>-specific (pentamer<sup>+</sup>) CD8<sup>+</sup> T cells (<xref rid="F5" ref-type="fig">Fig. 5a</xref>) revealed almost no significant differences between WT and LTβR<sup>−/−</sup> mice either before or during infection. The only exception was CD4<sup>+</sup> T cells on day 4 p.i., where WT and LTβR<sup>−/−</sup> mice showed a moderate decrease and increase, respectively. In both genotypes, the numbers of activated CD3<sup>+</sup>CD25<sup>+</sup> T cells were significantly increased on day 7 p.i., but LTβR<sup>−/−</sup> mice showed similar numbers of total T cells. In addition, LTβR<sup>−/−</sup> mice showed a comparable rise of activated CD3<sup>+</sup>CD25<sup>+</sup> T cells on day 7 p.i. and a comparable expansion of <named-content content-type="genus-species">T. gondii</named-content>-specific (pentamer<sup>+</sup>) CD8<sup>+</sup> T cells on day 10 p.i. (<xref rid="F5" ref-type="fig">Fig. 5a</xref>).</p>
                <fig position="float" id="F5">
                  <label>FIG 5</label>
                  <caption>
                    <p>Dysregulated immune cell numbers in LTβR<sup>−/−</sup> mice. (a) Absolute cell numbers of CD3<sup>+</sup>, CD4<sup>+</sup>, CD8<sup>+</sup>, CD25<sup>+</sup>CD3<sup>+</sup>, and pentamer<sup>+</sup>CD8<sup>+</sup> T cells. (b) CD19<sup>+</sup>, NK1.1<sup>+</sup>, and NK1.1<sup>+</sup>CD3<sup>+</sup> cells in spleens of uninfected (d0) and <named-content content-type="genus-species">T. gondii</named-content>-infected (ME49, 40 cysts, i.p.) WT and LTβR<sup>−/−</sup> mice (d0 to d7 p.i., <italic toggle="yes">n</italic> = 12; d10 p.i., <italic toggle="yes">n</italic> ≥ 6) determined via flow cytometry. (c) Representative tSNE plots from splenocytes of uninfected and <named-content content-type="genus-species">T. gondii</named-content>-infected (d10 p.i.) WT and LTβR<sup>−/−</sup> mice. Clustered populations were identified using the indicated markers. The data shown represent at least three independent experiments; symbols represent individual animals, columns represent mean values, and error bars represent the ± SEM. Two-way ANOVA corrected for multiple comparison using Tukey’s <italic toggle="yes">post hoc</italic> test was used for the statistical analysis represented in panels a and b. *, <italic toggle="yes">P</italic> &lt; 0.0332; **, <italic toggle="yes">P</italic> &lt; 0.0021; ***, <italic toggle="yes">P</italic> &lt; 0.0002; ****, <italic toggle="yes">P</italic> &lt; 0.0001.</p>
                  </caption>
                  <graphic xlink:href="iai.00026-21-f005" position="float"/>
                </fig>
                <p>Baseline numbers of CD19<sup>+</sup> B cells were somewhat higher in LTβR<sup>−/−</sup> mice and significantly increased on day 4 p.i., but while numbers of CD19<sup>+</sup> B cells dropped significantly in both genotypes on day 10 p.i., they were still significantly higher in LTβR<sup>−/−</sup> mice (<xref rid="F5" ref-type="fig">Fig. 5b</xref>).</p>
                <p>Since LTβR<sup>−/−</sup> mice are known to have fewer NK cells and NKT cells (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B52" ref-type="bibr">52</xref>), it was not surprising to observe that absolute NK1.1<sup>+</sup> cells were significantly higher in WT than in LTβR<sup>−/−</sup> mice before infection and on days 4 and 7 p.i. (<xref rid="F5" ref-type="fig">Fig. 5b</xref>). On day 10 p.i., NK1.1<sup>+</sup> cell numbers of both genotypes were similar, due to the drop of NK1.1<sup>+</sup> cells in spleens of WT mice during the course of infection. Similarly, the absolute numbers of NK1.1<sup>+</sup>CD3<sup>+</sup> NKT cells in WT mice declined during the course of infection but were higher than those of LTβR<sup>−/−</sup> mice before infection and on days 4 and 7 p.i., which is in accordance with published data (<xref rid="B51" ref-type="bibr">51</xref>). Unbiased analysis of the cytometry data set using t-distributed stochastic neighbor embedding (tSNE) (<xref rid="F5" ref-type="fig">Fig. 5c</xref>) confirmed these data, notably the absence of NK1.1<sup>+</sup> cells in uninfected LTβR<sup>−/−</sup> mice (1.46% and 0.04%, respectively) and the marked drop in absolute CD19<sup>+</sup> B cell numbers in WT mice by day 10 p.i. which was absent in LTβR<sup>−/−</sup> animals (59.03% to 2,26% versus 71.07% to 35.39%, respectively; <xref rid="F5" ref-type="fig">Fig. 5c</xref>). This demonstrates that the deficiency of the LTβR does not impact T cell numbers after <named-content content-type="genus-species">T. gondii</named-content> infection, especially the expansion of parasite-specific T cells, while it does seem to influence B cell numbers during the acute phase of <named-content content-type="genus-species">T. gondii</named-content> infection.</p>
                <p>In conclusion, LTβR<sup>−/−</sup> compared to WT mice do not show a significant difference in overall and antigen-specific T cell numbers either before or after <named-content content-type="genus-species">T. gondii</named-content> infection, but B cell, NK1.1<sup>+</sup>, and NKT cell numbers appear to be significantly affected by the absence of LTβR before and during infection.</p>
              </sec>
              <sec id="s2-10">
                <title>Impaired T cell effector function in the spleen in the absence of the LTβR.</title>
                <p>Even though LTβR<sup>−/−</sup> mice are highly susceptible to <named-content content-type="genus-species">T. gondii</named-content> infection, we detected comparable CD8<sup>+</sup> and <named-content content-type="genus-species">T. gondii</named-content>-specific CD8<sup>+</sup> T cell numbers in the spleen (<xref rid="F5" ref-type="fig">Fig. 5a</xref>). We therefore decided to determine whether these T cells were fully differentiated and functional with regard to their ability to produce IFN-γ, contained cytotoxic granules (GzmB<sup>+</sup> and perforin<sup>+</sup>), and were able to degranulate (CD107a<sup>+</sup> cells) upon stimulation. In order to address this question, splenocytes of infected WT and LTβR<sup>−/−</sup> mice (day 7 and 10 p.i.) were prepared and were restimulated <italic toggle="yes">ex vivo</italic> with toxoplasma lysate antigen (TLA) before flow cytometry analysis (<xref rid="F6" ref-type="fig">Fig. 6</xref>).</p>
                <fig position="float" id="F6">
                  <label>FIG 6</label>
                  <caption>
                    <p>LTβR deficiency impairs T cell effector function in the spleen. (a and b) Intracellular staining of (a) CD4<sup>+</sup>IFN-γ<sup>+</sup> and CD8<sup>+</sup>IFN-γ<sup>+</sup> T cells (%) and (b) cytotoxic granule (GzmB<sup>+</sup> or perforin<sup>+</sup>) containing and degranulating (CD107a<sup>+</sup>) pentamer<sup>+</sup>CD8<sup>+</sup> T cells of unstimulated and toxoplasma lysate antigen (TLA) <italic toggle="yes">ex vivo</italic> restimulated splenocytes from <named-content content-type="genus-species">T. gondii</named-content>-infected (d7 and 10 p.i.) WT and LTβR<sup>−/−</sup> mice (d7, <italic toggle="yes">n</italic> ≥ 6; d10, <italic toggle="yes">n</italic> ≥ 10). Representative data of at least two independent experiments; symbols represent individual animals, columns represent mean values, and error bars represent the ± SEM. Two-way ANOVA corrected for multiple comparison using Tukey’s <italic toggle="yes">post hoc</italic> test was used for statistical analysis. *, <italic toggle="yes">P</italic> &lt; 0.0332; **, <italic toggle="yes">P</italic> &lt; 0.0021; ****, <italic toggle="yes">P</italic> &lt; 0.0001.</p>
                  </caption>
                  <graphic xlink:href="iai.00026-21-f006" position="float"/>
                </fig>
                <p>After <italic toggle="yes">ex vivo</italic> TLA restimulation, LTβR<sup>−/−</sup> T cells compared to WT T cells showed a significantly reduced frequency of CD4<sup>+</sup> IFN-γ-producing T cells in splenocytes from day 7 p.i. and a reduced percentage in splenocytes at day 10 p.i. Similar frequencies for CD8<sup>+</sup> IFN-γ-producing T cells could be detected in restimulated splenocytes for both genotypes on both days (<xref rid="F6" ref-type="fig">Fig. 6a</xref>). There were no significant differences between the two genotypes for granzyme B-containing CD8<sup>+</sup> cells in restimulated cells from either day 7 or day 10 p.i. (Fig. S6a). For CD8<sup>+</sup>perforin<sup>+</sup> cells, WT mice showed higher frequencies in day 10 restimulated cells, but LTβR<sup>−/−</sup> mice showed a delayed but significant increase from day 7 to day 10, resulting in frequencies similar to those of WT mice for day 10 p.i. (Fig. S6a). In contrast, CD8<sup>+</sup>107a<sup>+</sup> T cell frequencies in WT spleens increased significantly in restimulated cells from day 10 p.i. and were significantly higher than those of LTβR<sup>−/−</sup> spleens (Fig. S6a). When we directly analyzed IFN-γ<sup>+</sup>GzmB<sup>+</sup> and IFN-γ<sup>+</sup>perforin<sup>+</sup> cells, we found a significantly higher frequency in restimulated splenocytes of WT mice at day 7 p.i. than those of LTβR<sup>−/−</sup> mice (Fig. S6b).</p>
                <p>For <named-content content-type="genus-species">T. gondii</named-content>-specific (pentamer<sup>+</sup>) CD8<sup>+</sup> T cells (<xref rid="F6" ref-type="fig">Fig. 6b</xref>), we found a significantly higher frequency of pentamer<sup>+</sup>CD8<sup>+</sup> IFN-γ-producing T cells in restimulated splenocytes from WT mice on day 7 p.i. compared to LTβR<sup>−/−</sup> mice but not in restimulated splenocytes from day 10 p.i. Interestingly, <named-content content-type="genus-species">T. gondii</named-content>-specific CD8<sup>+</sup>GzmB<sup>+</sup> T cells showed a similar picture—a significantly increased frequency in restimulated splenocytes from WT mice on day 7 p.i. compared to LTβR<sup>−/−</sup> mice and no difference of these cells in splenocytes from day 10 p.i. In WT compared to LTβR<sup>−/−</sup> spleens, <named-content content-type="genus-species">T. gondii</named-content>-specific CD8<sup>+</sup>perforin<sup>+</sup> T cells were also significantly higher in restimulated WT splenocytes at day 7 p.i. However, here, LTβR mice showed a significantly increased frequency of CD8<sup>+</sup>perforin<sup>+</sup> T cells in restimulated splenocytes from day 10 compared to day 7 p.i., resulting in similar frequencies for WT and LTβR<sup>−/−</sup> CD8<sup>+</sup>perforin<sup>+</sup> T cells at day 10 p.i. Finally, the percentage of <named-content content-type="genus-species">T. gondii</named-content>-specific CD8<sup>+</sup>CD107a<sup>+</sup> T cells was similar for both genotypes in restimulated splenocytes at day 7 p.i. but significantly increased for WT mice in restimulated splenocytes from day 10 p.i., whereas only few CD8<sup>+</sup> LTβR<sup>−/−</sup> T cells degranulated. To summarize, importantly, parasite-specific granzyme B granule containing (pentamer<sup>+</sup>CD8<sup>+</sup>GzmB<sup>+</sup>) as well as degranulating (pentamer<sup>+</sup>CD8<sup>+</sup>CD107a<sup>+</sup>) T cells do not appear to be detectable in LTβR<sup>−/−</sup> mice after <named-content content-type="genus-species">T. gondii</named-content> infection, whereas the increase of parasite-specific perforin granule-containing (pentamer<sup>+</sup>CD8<sup>+</sup>perforin<sup>+</sup>) T cells seems to be delayed in LTβR<sup>−/−</sup> compared to WT mice. These results demonstrate that while the T cell compartment does not seem to be affected in regard to cell numbers, LTβR<sup>−/−</sup> mice show a clear functional defect in the parasite-specific CD8<sup>+</sup> T cell compartment as well as clearly decreased IFN-γ-producing CD4<sup>+</sup> T cells after infection.</p>
              </sec>
              <sec id="s2-11">
                <title>LTβR deficiency abrogates <named-content content-type="genus-species">T. gondii</named-content>-specific isotype class switching.</title>
                <p>RNA-seq data of lung tissue from uninfected (day 0) and <named-content content-type="genus-species">T. gondii</named-content>-infected (day 7 p.i.) WT and LTβR<sup>−/−</sup> animals were further analyzed to elucidate the interaction between <named-content content-type="genus-species">T. gondii</named-content> and host immune responses. The data were filtered for differentially expressed genes, and hierarchical clustering was performed and illustrated as a sample dendrogram with a trait heat map (Fig. S7a) for identification of possible outliers. All tested samples showed adequate clustering and could, accordingly, be grouped into uninfected and infected WT and LTβR<sup>−/−</sup> mice. Next, gene expression data were condensed into 10 module eigengenes (ME0 to ME9; Fig. S7b) and used to generate a host-pathogen network prediction model (<xref rid="F7" ref-type="fig">Fig. 7a</xref>) displaying the relationship between modules (ME) and experimental conditions. This model captures the influence of <named-content content-type="genus-species">T. gondii</named-content> infection (“Infection” in the figure), the LTβR<sup>−/−</sup> genotype (“Genotype”), and total <named-content content-type="genus-species">T. gondii</named-content> genes (“X”) on host gene modules (ME0 to ME9) detected in each sample. Upon closer inspection, this model shows that LTβR expression (contained in ME6) is suppressed by the LTβR<sup>−/−</sup> genotype, which fits our experimental conditions. This model predicts that in WT mice, high expression of genes contained in ME6 suppresses genes contained in ME4 (top GO term “B cell receptor signaling pathway”) while enhancing gene expression in ME3 (top GO term “lymphocyte differentiation”). This implies that the loss of the LTβR slightly increases ME4 levels (Fig. S7c; top GO term “B cell receptor signaling pathway”; <xref rid="F7" ref-type="fig">Fig. 7a</xref>) containing genes for “immunoglobulin production” and “humoral immune response mediated by circulating immunoglobulin” during <named-content content-type="genus-species">T. gondii</named-content> infection. Furthermore, the network predicts that in LTβR<sup>−/−</sup> mice, <named-content content-type="genus-species">T. gondii</named-content> infection reduces ME3 levels (Fig. S7d; top GO term “lymphocyte differentiation”; <xref rid="F7" ref-type="fig">Fig. 7a</xref>) containing genes for “B cell activation” and “isotype switching.” In addition, GSEA generated from RNA-seq data also showed significant upregulation of these pathways, indicating a disturbed B cell response (Fig. S2).</p>
                <fig position="float" id="F7">
                  <label>FIG 7</label>
                  <caption>
                    <p>Abrogated parasite-specific isotype class switching and reconstitution of mice with <named-content content-type="genus-species">T. gondii</named-content>-specific immune serum. (a) Host-pathogen network prediction model generated based on RNA-seq data of lung tissue of uninfected (d0) and <named-content content-type="genus-species">T. gondii</named-content>-infected (ME49, 40 cysts; d7 p.i.) WT and LTβR<sup>−/−</sup> mice (<italic toggle="yes">n</italic> = 3/group). GmicR was used to detect relationships between module eigengenes (ME) and experimental conditions. X represents the total <named-content content-type="genus-species">T. gondii</named-content> gene expression data for each sample; infection and genotype were included as variables. Red lines indicate inverse and black lines positive relationships. Representative gene ontologies and hub genes reported by GmicR for each module are shown in the summary table. (b) <named-content content-type="genus-species">T. gondii</named-content>-specific IgM and IgG antibody response in serum of uninfected (d0) and <named-content content-type="genus-species">T. gondii</named-content>-infected (ME49, 40 cysts, i.p.) WT and LTβR<sup>−/−</sup> mice (d4 and d7 p.i., <italic toggle="yes">n</italic> = 15; d10 p.i., <italic toggle="yes">n</italic> ≥ 20). Shown is a representative result of four independent experiments; bars represent mean values ± SEM. (c) Transfer of serum (red arrows; d1, d3, d7, and d11 p.i.) from uninfected donor WT mice (control serum) or from <named-content content-type="genus-species">T. gondii</named-content>-infected (ME49, 20 cysts, i.p.) donor WT mice (immune serum) into WT and LTβR<sup>−/−</sup> acceptor mice. On day 0, acceptor mice (<italic toggle="yes">n</italic> = 6/group) were infected with <named-content content-type="genus-species">T. gondii</named-content> (ME49, 10 cysts, i.p.), and survival was evaluated. IFN-γR<sup>−/−</sup> mice (<italic toggle="yes">n</italic> = 3) served as infection controls. The data shown in panel c represent one experiment. A log rank (Mantel Cox) test was used for the statistical analysis represented in panel c. *, <italic toggle="yes">P</italic> &lt; 0.0332; n.d., not detected.</p>
                  </caption>
                  <graphic xlink:href="iai.00026-21-f007" position="float"/>
                </fig>
                <p>Due to this highly surprising prediction, as well as the different B cell numbers of WT and LTβR<sup>−/−</sup> mice in the spleen on day 10 p.i. (<xref rid="F5" ref-type="fig">Fig. 5a</xref> and <xref rid="F5" ref-type="fig">c</xref>), we then asked whether an altered B cell-mediated humoral immune response could be directly involved in the high mortality of LTβR<sup>−/−</sup> mice after <named-content content-type="genus-species">T. gondii</named-content> infection. The presence of immunoglobulin M (IgM) and IgG antibodies specific for <named-content content-type="genus-species">T. gondii</named-content> antigens was determined during the acute phase of infection (days 4, 7, and 10 p.i.) using line blots coated with specific recombinant <named-content content-type="genus-species">T. gondii</named-content> tachyzoite and bradyzoite antigens (ROP1c, GRA7, GRA8, p30, and MAG1). LTβR<sup>−/−</sup> mice compared to WT mice showed a delayed and reduced <named-content content-type="genus-species">T. gondii</named-content>-specific IgM and, surprisingly, an abrogated <named-content content-type="genus-species">T. gondii</named-content>-specific IgG antibody response in the serum during infection (days 4, 7, and 10 p.i.; <xref rid="F7" ref-type="fig">Fig. 7b</xref>), demonstrating a lack of functional isotype switching that is in line with the bioinformatic host-pathogen prediction network.</p>
              </sec>
              <sec id="s2-12">
                <title>LTβR deficiency can be partially compensated for by transfer of <named-content content-type="genus-species">T. gondii</named-content> immune serum.</title>
                <p>Since it has been described that a <named-content content-type="genus-species">T. gondii</named-content>-specific IgG response is required for a reduction of the parasite burden (<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B51" ref-type="bibr">51</xref>), we treated LTβR<sup>−/−</sup> mice with serum from <named-content content-type="genus-species">T. gondii</named-content>-infected WT animals (immune serum) and uninfected mice (control serum) and monitored survival after <named-content content-type="genus-species">T. gondii</named-content> infection (<xref rid="F7" ref-type="fig">Fig. 7c</xref>). Serum transfer experiments showed that LTβR<sup>−/−</sup> mice treated with immune serum exhibit significantly prolonged survival (up to day 14 p.i.) compared to littermates that received control serum, which died by day 11 p.i. IFN-γR<sup>−/−</sup> mice served as infection controls and succumbed as reported around day 8 p.i. (<xref rid="B53" ref-type="bibr">53</xref>). These data demonstrate that LTβR-mediated signaling is essential for the development of an efficient humoral immune response to <named-content content-type="genus-species">T. gondii</named-content> infection.</p>
              </sec>
            </sec>
            <sec sec-type="discussion" id="s3">
              <title>DISCUSSION</title>
              <p>The results obtained in this study corroborate a profoundly deficient immune response of LTβR<sup>−/−</sup> mice to <named-content content-type="genus-species">T. gondii</named-content> infection and reveal an impaired IFN response, a severe functional T cell defect, as well as a humoral immune deficiency in the absence of LTβR.</p>
              <p>One reason for the significantly increased parasite burden and significantly reduced survival rates of LTβR<sup>−/−</sup> mice is the inadequate cytokine, especially the IFN-γ, response. The elevated levels of LTα and significantly increased levels of LTβ in the lung of LTβR<sup>−/−</sup> mice could be caused by compensatory mechanisms and/or lack of negative feedback mechanisms due to the absence of the LTβR. Since we also found elevated levels for IFN-γ, IL-6, IFN-β, IL-1α, and IL-17A and significantly elevated expression levels for IL-1β in the serum and for IL-4 in the lung, we suggest that, overall, uninfected LTβR<sup>−/−</sup> mice show a dysregulated, more activated, albeit stable immune homeostasis. This is in accordance with the finding that LTβR<sup>−/−</sup> animals present with splenomegaly, probably due to microbiota-mediated inflammation (<xref rid="B54" ref-type="bibr">54</xref>). When <named-content content-type="genus-species">T. gondii</named-content> infection disrupts this precarious balance in LTβR<sup>−/−</sup> mice, the dysregulation becomes more pronounced; on the one hand, LTβR<sup>−/−</sup> mice have lower levels of IFN-γ in the serum early during infection, but on day 10 p.i., when WT mice already show decreased IFN-γ levels, they remain high in LTβR<sup>−/−</sup> mice, not only in serum but also in the lungs. Conversely, IL-6 expression in the serum is markedly increased in LTβR<sup>−/−</sup> mice compared to WT mice throughout the infection. This suggests that by day 10 p.i., parasite expansion is being controlled in WT but not LTβR<sup>−/−</sup> mice. The significantly increased levels of IL-10 in LTβR mice on day 10 <italic toggle="yes">p.i.</italic> could be a protective/counteractive mechanism to prevent extensive immunopathology (<xref rid="B55" ref-type="bibr">55</xref>). Interestingly, several cytokines in LTβR<sup>−/−</sup> mice are transiently but significantly upregulated on day 4 p.i. This also suggests a disruption of the precarious immune homeostasis in LTβR mice. In contrast to the activated immune homeostasis in LTβR<sup>−/−</sup> mice, they show decreased expression levels for chemokines/chemokine receptors, genes involved in IFN-γ signaling, and IFN-γ-induced genes in the lung on day 7 p.i. This points toward an inability of LTβR<sup>−/−</sup> mice to mount an efficient immune response to <named-content content-type="genus-species">T. gondii</named-content> infection and is supported by the finding that upregulation of IFN-γ-regulated effector molecules known to be important for <named-content content-type="genus-species">T. gondii</named-content> containment, such as iNOS, IDO1, NOX2-gp91phox, and mGBPs, is deficient in LTβR animals. In the lung, in the case of NOX2-gp91phox, this could be due to the lack of TNF-α expression, as it has been shown in <italic toggle="yes">ex vivo</italic> experiments of bronchoalveolar fluid cells and human pulmonary artery endothelial cells that TNF-α upregulates NOX2-g91phox (<xref rid="B56" ref-type="bibr">56</xref>, <xref rid="B57" ref-type="bibr">57</xref>). The mRNA expression profile of mGBPs and the protein expression of mGBPs 2 and 7 also fit into this pattern; mGBPs are essential for efficient control of <named-content content-type="genus-species">T. gondii</named-content> expansion (<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B58" ref-type="bibr">58</xref>), and RNA-seq analysis shows that uninfected LTβR mice have overall increased expression of, while infected animals show overall less upregulation. And while LTβR<sup>−/−</sup> animals do upregulate mGBP expression during the course of infection, they show significantly lower expression on day 10 p.i. than WT mice in all cases except for mGBP6/10.</p>
              <p>LTβR<sup>−/−</sup> animals also show increased baseline expression of IFN-γ mRNA in the lung, which would explain the elevated baseline JAK1 protein expression. Increased JAK expression should lead to increased JAK phosphorylation and, consequently, increased STAT1 recruitment and STAT1 phosphorylation (<xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B60" ref-type="bibr">60</xref>). However, we observed delayed upregulation of STAT1 and less pSTAT1 protein in infected LTβR<sup>−/−</sup> animals and therefore hypothesize that the lack of LTβR signaling somehow affects STAT1 expression or recruitment via a so far unknown mechanism. Notably, Kutsch et al. also showed reduced STAT1 expression in LTβR<sup>−/−</sup> mice (<xref rid="B61" ref-type="bibr">61</xref>).</p>
              <p>We conclude that, due to the underlying dysregulation of the immune homeostasis, LTβR<sup>−/−</sup> mice are unable to initiate a coordinated immune response, leading to either delayed upregulation of essential cytokines (e.g., IFN-γ) or overexpression of others (e.g., IL-6, TNF). This is also supported by our findings that LTβR<sup>−/−</sup> mice do not show the typical splenomegaly associated with (<named-content content-type="genus-species">T. gondii</named-content>) infection (<xref rid="B39" ref-type="bibr">39</xref>).</p>
              <p>In line with published data, we found a virtual absence of NK1.1<sup>+</sup> cells in LTβR<sup>−/−</sup> mice, and NK1.1<sup>+</sup> cell numbers dropped in WT mice after infection, probably due to conversion into ILCs (<xref rid="B51" ref-type="bibr">51</xref>). Also, a lack of NKT cells has been shown for LTβR<sup>−/−</sup> mice (<xref rid="B62" ref-type="bibr">62</xref>). Interestingly, a dual role for NKT cells in <named-content content-type="genus-species">T. gondii</named-content> infection has been described; on the one hand, they release large amounts of IL-4 and IFN-γ upon activation to shift the T cell response toward a Th1 pattern, and on the other hand, the uncontrolled Th1 response can lead to severe immunopathology (<xref rid="B63" ref-type="bibr">63</xref>). Since they have also been indicated in the suppression of a protective immunity against <named-content content-type="genus-species">T. gondii</named-content> infection (<xref rid="B64" ref-type="bibr">64</xref>), it is maybe not surprising that their numbers are downregulated after infection in WT animals.</p>
              <p>Overall, we did not find T cell numbers to be significantly different in either uninfected or <named-content content-type="genus-species">T. gondii</named-content>-infected LTβR<sup>−/−</sup> mice compared to WT mice. However, we found profound defects in T cell effector functions; the reduced number of IFN-γ-producing CD4<sup>+</sup> T cells and functional <named-content content-type="genus-species">T. gondii</named-content>-specific CD8<sup>+</sup> cytotoxic lymphocytes (GzmB<sup>+</sup>, perforin+, CD107a<sup>+</sup>) strongly implies that cytotoxic T cell-mediated killing is severely impaired in LTβR<sup>−/−</sup> animals. Since these responses are known to be essential for efficient <named-content content-type="genus-species">T. gondii</named-content> containment, this marked functional deficiency is probably one reason for the susceptibility of LTβR<sup>−/−</sup> mice to the parasite.</p>
              <p>In contrast to T cell numbers, B cell numbers differed significantly in LTβR<sup>−/−</sup> mice compared to WT mice. On day 10 postinfection, the numbers of CD19<sup>+</sup> B cells in WT spleens were significantly lower than those of LTβR<sup>−/−</sup> animals. This is probably due to maturation of B cells to IgG-producing plasma cells in WT mice, which emigrate to the bone marrow and lose surface CD19 in the process. In LTβR<sup>−/−</sup> mice, the lack of class switching would inhibit maturation and migration of B cells to the bone marrow.</p>
              <p>Since the host-pathogen network prediction model we generated from <named-content content-type="genus-species">T. gondii</named-content>-infected mice indicated that the loss of the LTβR inhibits B cell responses, including isotype switching in <named-content content-type="genus-species">T. gondii</named-content> infection, we further analyzed the humoral immune response. We demonstrated that <named-content content-type="genus-species">T. gondii</named-content>-infected LTβR<sup>−/−</sup> mice produced less <named-content content-type="genus-species">T. gondii</named-content>-specific IgM than WT mice, and no detectable <named-content content-type="genus-species">T. gondii</named-content>-specific IgG. Whether this failure is due to impaired IFN-γ production which is an important cytokine for isotype class switching (<xref rid="B65" ref-type="bibr">65</xref>) will be determined in the future.</p>
              <p>While Glatman Zaretsky et al. (<xref rid="B39" ref-type="bibr">39</xref>) argue that the disrupted lymphoid structure, which includes the lack of defined germinal centers in LTβR<sup>−/−</sup> mice, is the main cause of the reduced antibody response, Ehlers et al. (<xref rid="B5" ref-type="bibr">5</xref>) show via bone marrow (BM) chimeras that the effects of LTβR deficiency in <named-content content-type="genus-species">M. tuberculosis</named-content> infection cannot be attributed solely to the architectural differences but are also directly caused by the lack of LTβR-mediated signaling. LTα, another member of the TNF/TNFR superfamily, has similar but not identical functions to LTβ in the development of secondary lymphoid organs and immune modulation (<xref rid="B2" ref-type="bibr">2</xref>). LTα<sup>−/−</sup> animals also present with a disturbed architecture of the lymphoid system (no LNs, no PPs, no germinal centers, and a disorganized white pulp) (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B66" ref-type="bibr">66</xref>). <named-content content-type="genus-species">T. gondii</named-content>-infected LTα<sup>−/−</sup> mice are shown to have reduced numbers of <named-content content-type="genus-species">T. gondii</named-content>-specific IFN-γ-producing T cells and lower <named-content content-type="genus-species">T. gondii</named-content>-specific antibody titers, but BM chimera experiments demonstrated that an intact secondary lymphoid system is not sufficient to generate an effective immune response (<xref rid="B25" ref-type="bibr">25</xref>). Interestingly, the study of Glatman Zaretsky et al. (<xref rid="B39" ref-type="bibr">39</xref>), which uses the <named-content content-type="genus-species">T. gondii</named-content> Prugniaud strain, also a type II strain, found parasite-specific IgM in serum as early as day 7 postinfection in WT animals, which is in line with our observations in this study. This indicates a comparable timeline in the induction of immune responses and antiparasitic effector mechanisms in WT animals to <named-content content-type="genus-species">T. gondii</named-content> in the two type II strains. We therefore feel confident that our results are representative of the infections with a type II strain, which are the prevalent strains in human toxoplasmosis in North America and Europe (<xref rid="B67" ref-type="bibr">67</xref><xref rid="B68" ref-type="bibr">–</xref><xref rid="B70" ref-type="bibr">70</xref>).</p>
              <p>Although protective B cell responses have been described to play a more significant role in chronic rather than acute <named-content content-type="genus-species">T. gondii</named-content> infection in some <named-content content-type="genus-species">T. gondii</named-content> infection models (<xref rid="B49" ref-type="bibr">49</xref><xref rid="B50" ref-type="bibr">–</xref><xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B71" ref-type="bibr">71</xref>), our data indicate that a robust humoral immune response is dependent on LTβR signaling and is a prerequisite for survival during acute <named-content content-type="genus-species">T. gondii</named-content> infection. This conclusion is validated by our data showing that the survival of LTβR<sup>−/−</sup> animals can be significantly prolonged by transfer of immune serum containing <named-content content-type="genus-species">T. gondii</named-content>-specific antibodies.</p>
              <p>Finally, the host-pathogen prediction network generated in this study indicates that <named-content content-type="genus-species">T. gondii</named-content> infection suppresses B cell responses in WT animals. This could point toward an unknown <named-content content-type="genus-species">T. gondii</named-content> strategy to evade the host immune system. Early <named-content content-type="genus-species">T. gondii</named-content>-mediated suppression of B cell responses could support dissemination and cyst formation in the brain, facilitating the establishment of chronic infection (<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B72" ref-type="bibr">72</xref>). Since <named-content content-type="genus-species">T. gondii</named-content> is known to have developed different mechanisms to evade host immune responses (<xref rid="B73" ref-type="bibr">73</xref>), it is worth exploring this approach in the future.</p>
              <p>We demonstrate that the loss of LTβR signaling results in a combined and profoundly depressed IFN-γ response, impaired T cell functionality, and the failure to induce parasite-specific IgG antibodies, leading to an increase in parasite burden and fatal outcome of <named-content content-type="genus-species">T. gondii</named-content> infection. Therefore, for the first time, we suggest an LTβR-mediated modulation of the IFN-γ signaling pathway <italic toggle="yes">in vivo</italic>. Further understanding of this complex interplay between LTβR and IFN-γ signaling pathways will provide new insights into the pathogenesis of <named-content content-type="genus-species">T. gondii</named-content> and may provide novel therapeutic strategies.</p>
            </sec>
            <sec sec-type="materials|methods" id="s4">
              <title>MATERIALS AND METHODS</title>
              <sec id="s4-1">
                <title>Mice.</title>
                <p>LTβR<sup>−/−</sup> mice were previously described (<xref rid="B7" ref-type="bibr">7</xref>) and are back-crossed for at least 10 generations onto a C57BL/6N background. Wild-type (WT) littermates were used as controls. Mice were kept under specific-pathogen-free (SPF) conditions in the animal facility at the Heinrich Heine University Düsseldorf and were 8 to 16 weeks old for experiments. Cysts of the ME49 strain (substrain 2017) of <named-content content-type="genus-species">T. gondii</named-content> were collected from the brain tissue of chronically infected CD1 mice. All animal experiments were conducted in strict accordance with the German Animal Welfare Act. The protocols were approved by the local authorities (Permit no. 84-02.04.2013.A495, 81-02.04.2018.A406, and 81-02.05.40.18.082). All applicable international, national, and institutional guidelines for the care and use of animals were followed.</p>
              </sec>
              <sec id="s4-2">
                <title><named-content content-type="genus-species">Toxoplasma gondii</named-content> infection experiments.</title>
                <p>Mice were intraperitoneally (i.p.) infected with 40 cysts (ME49 strain) and weighed and scored daily for the duration of the experiments. Mice were euthanized on days 4, 7, and 10 postinfection (dpi); uninfected mice (d0) served as controls. After euthanasia (100 mg/kg ketamine, 10 mg/kg xylazine; Vétoquinol GmbH), blood was taken from the vena cava inferior, and spleen, lung, and muscle tissue was harvested for analysis.</p>
              </sec>
              <sec id="s4-3">
                <title>Detection of parasite load.</title>
                <p>Total DNA was isolated from tissues using a DNA isolation kit (Genekam) according to the manufacturer’s protocol. qRT-PCR was performed on a Bio-Rad CFX-96 Touch real-time detection system. To determine parasite load, PCR of DNA isolated from defined numbers (101 to 105) of <italic toggle="yes">in vitro</italic>-cultured ME49 tachyzoites (using distilled water [dH<sub>2</sub>O] as a negative control) was performed to generate a standard curve; TgB1 primers and probe (Metabion) were used to amplify a defined sequence of the 35-fold repetitive B1 gene from <named-content content-type="genus-species">T. gondii</named-content> and are listed in Table S1. This <named-content content-type="genus-species">T. gondii</named-content> standard curve was used to determine B1 amplification for calculation of parasite load.</p>
              </sec>
              <sec id="s4-4">
                <title>Cytokine measurement.</title>
                <p>Cytokines CCL2, IFN-γ, IFN-β, IL-1α, IL-1β, IL-6, IL-10, IL12p70, IL-17A, IL-23, IL-27, and TNF-α were measured using the LEGENDplex mouse inflammation panel (BioLegend) according to the manufacturer’s protocol. Samples were measured using a BD FACSCanto II instrument.</p>
              </sec>
              <sec id="s4-5">
                <title>Real-time qRT-PCR.</title>
                <p>Total RNA was isolated from tissues using the TRIzol reagent (Invitrogen) according to the manufacturer’s protocol. cDNA was reverse-transcribed using SuperScript III reverse transcriptase (200 U/μl; Invitrogen). qRT-PCR was performed on the Bio-Rad CFX-96 Touch real-time detection system. The primer sequences and corresponding probes (Metabion, Roche, and TIB Molbiol) are listed in Table S1. Results are expressed relative to expression in untreated WT mice normalized to β-actin (2<sup>–ΔΔ</sup><italic toggle="yes"><sup>CT</sup></italic>).</p>
              </sec>
              <sec id="s4-6">
                <title>RNA-seq analysis.</title>
                <p>Lung tissue of uninfected (d0) and <named-content content-type="genus-species">T. gondii</named-content>-infected (ME49 strain, 40 cysts, i.p.) WT and LTβR<sup>−/−</sup> mice was obtained, and RNA sequencing was performed on a HiSeq 3000 device. Mouse and <named-content content-type="genus-species">T. gondii</named-content> transcripts were quantified from FASTQ files using Salmon with default settings and GC bias compensation. For transcriptome models, <named-content content-type="genus-species">Mus musculus</named-content> GRCm38 cDNA (<ext-link xlink:href="http://ensembl.org" ext-link-type="uri">ensembl.org</ext-link>, release-97) and <italic toggle="yes">Tgondii</italic>ME49 annotated transcripts (<ext-link xlink:href="http://toxodb.org" ext-link-type="uri">toxodb.org</ext-link>, ToxoDB-45) were used. Mouse transcripts from pseudogenes or with retained introns were excluded prior to conversion to gene counts using the DESeq2 package. Non-protein-encoding <named-content content-type="genus-species">T. gondii</named-content> transcripts were excluded prior to conversion to gene counts. DEseq2 was used to test for genotype-specific responsiveness to infection with the following model: ∼genotype · infection. To calculate WT-specific responsiveness, we used the following model: ∼genotype + genotype: infection. For significance, the Wald test with an adjusted <italic toggle="yes">P</italic> value of 0.1 was used.</p>
              </sec>
              <sec id="s4-7">
                <title>Host-pathogen network generation.</title>
                <p>Previously developed analytic tools for ’omics data sets were used to generate the host-pathogen network as described (<xref rid="B74" ref-type="bibr">74</xref>). Prior to network generation, the variance stabilizing transformation (VST)-normalized data were filtered for genes that showed significant differential expression for at least one contrast. This produced an expression matrix for 10,748 genes. The GmicR package was then used for module detection, using a minimum module size of 30, mergeCutHeight of 0.3, and Rsquared cut of 0.80. To detect relationships between modules and infection, VST-normalized data <named-content content-type="genus-species">T. gondii</named-content> expression levels for each sample were aggregated by sum, and then these numeric data were merged to module eigengenes using the Data_Prep function of GmicR (Fig. S6). Genotype and infection conditions were merged with the discretized data. A white list indicating the parent-to-child relationship from “genotype” to “ME6” corresponding to the module containing LTβR was included in the Bayesian network learning process. A final network was generated using the bn_tabu_gen function with 500 bootstrap replicates, “bds” score, and iss set to 1. Inverse relationships between nodes were detected using the InverseARCs function from GmicR with default settings.</p>
              </sec>
              <sec id="s4-8">
                <title>Immunoblot analysis and antibodies.</title>
                <p>Tissues were homogenized in phosphate-buffered saline (PBS) containing cOmplete protease inhibitor cocktail (Roche) using the Precellys homogenizer (Bertin). The protein concentration was measured using the Pierce BCA protein assay kit (Thermo Scientific) according to the manufacturer’s protocol. Samples (10 μg/lane) were separated by 4 to 12% SDS-PAGE, followed by electrophoretic transfer to nitrocellulose membranes before blocking and incubation with the primary antibodies listed in Table S2. Horseradish peroxidase (HRP)-labeled anti-rabbit or anti-mouse antibodies (Cell Signaling Technologies) were used as secondary antibodies. Relative signal intensity of protein bands was quantified using ImageJ (NIH).</p>
              </sec>
              <sec id="s4-9">
                <title>tSNE.</title>
                <p>The cloud-based platform Cytobank (<xref rid="B75" ref-type="bibr">75</xref>) (Mountain View) was used for visualization of flow cytometry data. A total of 60,000 events per sample were analyzed (parameters: iterations, 2,400; perplexity, 80; Theta, 0.5) before overlaid dot plots were generated.</p>
              </sec>
              <sec id="s4-10">
                <title>Flow cytometry.</title>
                <p>Spleens were harvested and digested for 30 min at 37°C using collagenase D (100 mg/ml) and DNase I (20,000 U/ml). Tissue digest was stopped using 1× PBS containing 10 mM EDTA before cell solution was filtered using a 70-μm cell strainer. A red blood cell (RBC) lysis (Merck) was performed before cell numbers were calculated. Single-cell suspended splenocytes (1 × 10<sup>6</sup> cells) were stained with the fixable viability dye eFluor 780 (eBioscience). Surface staining with antibodies specific for CD3e (145-2c11), CD4 (RM4-5), CD8a (53-6.7), CD19 (6D5), CD25 (3C7), and NK1.1 (PK136), all purchased from BioLegend (expect for CD4, which as purchased from BD Bioscience), was performed. For intracellular staining, splenocytes were incubated for 20 h with toxoplasma lysate antigen (TLA, 15 μg/ml) before brefeldin A (eBioscience) was added for an additional 4 h. After surface staining with anti-CD4 (RM4-5), anti-CD8a (53-6.7), anti-CD107a (1D4B), and anti-TCRb (H57-597), cells were fixed, permeabilized, and stained with anti-IFN-γ (XMG1.2), anti-granzyme B (QA16A02), and antiperforin (S16009A) (all purchased from BioLegend) using a Fix &amp; Perm cell permeabilization kit (Life Technologies) according to the manufacturer’s protocol. Major histocompatibility complex class I-SVLAFRRL pentamer was purchased from ProImmune and used in experiments as indicated. BD Calibrate beads (BD Bioscience) were added to the samples before acquisition with a BD LSRFortessa instrument.</p>
              </sec>
              <sec id="s4-11">
                <title>Detection of <named-content content-type="genus-species">T. gondii</named-content>-specific antibodies.</title>
                <p>A RecomLine <italic toggle="yes">Toxoplasma</italic> IgG/IgM kit (Mikrogen Diagnostik) was used to detect IgM and IgG antibodies against <named-content content-type="genus-species">T. gondii</named-content> in serum. Anti-human IgM and IgG conjugates provided within the kit were replaced with anti-mouse IgM-HRP-labeled (Invitrogen) and anti-mouse IgG-HRP-labeled (Invitrogen) conjugates. Otherwise, the assay was performed according to the manufacturer’s protocol.</p>
              </sec>
              <sec id="s4-12">
                <title>Serum transfer.</title>
                <p>Blood from naive donor mice (control serum) or WT mice infected i.p. with 20 cysts of the ME49 strain of <named-content content-type="genus-species">T. gondii</named-content> (immune serum) was collected from the vena cava inferior. After 2 h of incubation at room temperature (RT), serum was collected by centrifugation of the blood. Acceptor WT and LTβR<sup>−/−</sup> mice were reconstituted intraperitoneally with 0.2 ml serum 1 day prior to infection (d-1) as well as on days 3, 7, and 11 p.i. Acceptor (WT and LTβR<sup>−/−</sup>) mice as well as IFN-γ<sup>−/−</sup> control mice were intraperitoneally infected with 10 cysts (ME49 strain) and weighed and scored daily for the duration of the experiment. <named-content content-type="genus-species">T. gondii</named-content>-specific antibodies were detected via line blots to confirm the presence and assess the amount of <named-content content-type="genus-species">T. gondii</named-content>-specific antibodies in control and immune serum.</p>
              </sec>
              <sec id="s4-13">
                <title>Statistical analysis.</title>
                <p>Data were analyzed with Prism version 8 (GraphPad) using a log rank (Mantel Cox) test or 2-way analysis of variance (ANOVA) corrected for multiple comparison by the Tukey’s or Sidak’s <italic toggle="yes">post hoc</italic> test as indicated in the figure legends. Symbols represent individual animals, columns represent mean values, and error bars represent the ± standard error of the mean (SEM). <italic toggle="yes">P</italic> values of ≤0.0332 were considered statistically significant and marked with asterisks. <italic toggle="yes">P</italic> values of ≥0.0332 were considered statistically not significant and were not specifically marked.</p>
              </sec>
              <sec id="s4-14">
                <title>Data availability.</title>
                <p>The data that support the findings of this study are available from the corresponding author.</p>
              </sec>
            </sec>
          </body>
          <back>
            <ack>
              <title>ACKNOWLEDGMENTS</title>
              <p>We thank Nicole Küpper, Julia Mock, and Karin Buchholz for technical assistance. Computational support of the Zentrum für Informations und Medientechnologie, especially the HPC team (High Performance Computing) at the Heinrich Heine University is acknowledged.</p>
              <p>This work was supported by the Jürgen Manchot Foundation (Molecules of Infection III [MOI III]). C.F.W. has sponsored research projects with E. Lilly Co. and Capella Biosciences. C.F.W. was supported in part by Perkins Family Foundation and NIH R01AI158552. R.V.-S. was supported by a Perkins Family Foundation fellowship.</p>
              <p>A.T. performed and analyzed all experiments, except for <xref rid="F2" ref-type="fig">Fig. 2a</xref>, <xref rid="F3" ref-type="fig">3a</xref>, <xref rid="F4" ref-type="fig">4</xref>, and <xref rid="F7" ref-type="fig">7a</xref> as well as Fig. S2 and S7; R.V.-S. developed the immune network models for analysis of RNA-seq data sets. M.H. performed the experiments illustrated in <xref rid="F4" ref-type="fig">Fig. 4</xref>. P.P. and K.K. performed the RNA sequencing. A.T., U.R.S., and K.P. wrote the manuscript with input from D.D., I.R.D., and C.F.W. K.P., U.R.S. and A.T. designed the study.</p>
              <p>We declare no competing interests.</p>
            </ack>
            <fn-group>
              <fn fn-type="supplementary-material">
                <p>Supplemental material is available online only.</p>
                <p>
                  <inline-supplementary-material id="fS1" xlink:href="iai.00026-21-s0001.pdf" content-type="local-data"/>
                </p>
              </fn>
            </fn-group>
            <ref-list>
              <title>REFERENCES</title>
              <ref id="B1">
                <label>1</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ward-Kavanagh</surname><given-names>LK</given-names></string-name>, <string-name><surname>Lin</surname><given-names>WW</given-names></string-name>, <string-name><surname>Sedy</surname><given-names>JR</given-names></string-name>, <string-name><surname>Ware</surname><given-names>CF</given-names></string-name></person-group>. <year>2016</year>. <article-title>The TNF receptor superfamily in co-stimulating and co-inhibitory responses</article-title>. <source>Immunity</source><volume>44</volume>:<fpage>1005</fpage>–<lpage>1019</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2016.04.019</pub-id>.<pub-id pub-id-type="pmid">27192566</pub-id></mixed-citation>
              </ref>
              <ref id="B2">
                <label>2</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hehlgans</surname><given-names>T</given-names></string-name>, <string-name><surname>Pfeffer</surname><given-names>K</given-names></string-name></person-group>. <year>2005</year>. <article-title>The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games</article-title>. <source>Immunology</source><volume>115</volume>:<fpage>1</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2567.2005.02143.x</pub-id>.<pub-id pub-id-type="pmid">15819693</pub-id></mixed-citation>
              </ref>
              <ref id="B3">
                <label>3</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schneider</surname><given-names>K</given-names></string-name>, <string-name><surname>Potter</surname><given-names>KG</given-names></string-name>, <string-name><surname>Ware</surname><given-names>CF</given-names></string-name></person-group>. <year>2004</year>. <article-title>Lymphotoxin and LIGHT signaling pathways and target genes</article-title>. <source>Immunol Rev</source><volume>202</volume>:<fpage>49</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1111/j.0105-2896.2004.00206.x</pub-id>.<pub-id pub-id-type="pmid">15546385</pub-id></mixed-citation>
              </ref>
              <ref id="B4">
                <label>4</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ware</surname><given-names>CF</given-names></string-name></person-group>. <year>2005</year>. <article-title>Network communications: lymphotoxins, LIGHT, and TNF</article-title>. <source>Annu Rev Immunol</source><volume>23</volume>:<fpage>787</fpage>–<lpage>819</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.immunol.23.021704.115719</pub-id>.<pub-id pub-id-type="pmid">15771586</pub-id></mixed-citation>
              </ref>
              <ref id="B5">
                <label>5</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ehlers</surname><given-names>S</given-names></string-name>, <string-name><surname>Holscher</surname><given-names>C</given-names></string-name>, <string-name><surname>Scheu</surname><given-names>S</given-names></string-name>, <string-name><surname>Tertilt</surname><given-names>C</given-names></string-name>, <string-name><surname>Hehlgans</surname><given-names>T</given-names></string-name>, <string-name><surname>Suwinski</surname><given-names>J</given-names></string-name>, <string-name><surname>Endres</surname><given-names>R</given-names></string-name>, <string-name><surname>Pfeffer</surname><given-names>K</given-names></string-name></person-group>. <year>2003</year>. <article-title>The lymphotoxin beta receptor is critically involved in controlling infections with the intracellular pathogens Mycobacterium tuberculosis and Listeria monocytogenes</article-title>. <source>J Immunol</source><volume>170</volume>:<fpage>5210</fpage>–<lpage>5218</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.170.10.5210</pub-id>.<pub-id pub-id-type="pmid">12734369</pub-id></mixed-citation>
              </ref>
              <ref id="B6">
                <label>6</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Spahn</surname><given-names>TW</given-names></string-name>, <string-name><surname>Maaser</surname><given-names>C</given-names></string-name>, <string-name><surname>Eckmann</surname><given-names>L</given-names></string-name>, <string-name><surname>Heidemann</surname><given-names>J</given-names></string-name>, <string-name><surname>Lugering</surname><given-names>A</given-names></string-name>, <string-name><surname>Newberry</surname><given-names>R</given-names></string-name>, <string-name><surname>Domschke</surname><given-names>W</given-names></string-name>, <string-name><surname>Herbst</surname><given-names>H</given-names></string-name>, <string-name><surname>Kucharzik</surname><given-names>T</given-names></string-name></person-group>. <year>2004</year>. <article-title>The lymphotoxin-beta receptor is critical for control of murine Citrobacter rodentium-induced colitis</article-title>. <source>Gastroenterology</source><volume>127</volume>:<fpage>1463</fpage>–<lpage>1473</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2004.08.022</pub-id>.<pub-id pub-id-type="pmid">15521015</pub-id></mixed-citation>
              </ref>
              <ref id="B7">
                <label>7</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Futterer</surname><given-names>A</given-names></string-name>, <string-name><surname>Mink</surname><given-names>K</given-names></string-name>, <string-name><surname>Luz</surname><given-names>A</given-names></string-name>, <string-name><surname>Kosco-Vilbois</surname><given-names>MH</given-names></string-name>, <string-name><surname>Pfeffer</surname><given-names>K</given-names></string-name></person-group>. <year>1998</year>. <article-title>The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues</article-title>. <source>Immunity</source><volume>9</volume>:<fpage>59</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/s1074-7613(00)80588-9</pub-id>.<pub-id pub-id-type="pmid">9697836</pub-id></mixed-citation>
              </ref>
              <ref id="B8">
                <label>8</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname><given-names>Q</given-names></string-name>, <string-name><surname>Sun</surname><given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname><given-names>J</given-names></string-name>, <string-name><surname>Lin</surname><given-names>X</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Pegg</surname><given-names>LE</given-names></string-name>, <string-name><surname>Futterer</surname><given-names>A</given-names></string-name>, <string-name><surname>Pfeffer</surname><given-names>K</given-names></string-name>, <string-name><surname>Fu</surname><given-names>YX</given-names></string-name></person-group>. <year>2001</year>. <article-title>Signal via lymphotoxin-beta R on bone marrow stromal cells is required for an early checkpoint of NK cell development</article-title>. <source>J Immunol</source><volume>166</volume>:<fpage>1684</fpage>–<lpage>1689</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.166.3.1684</pub-id>.<pub-id pub-id-type="pmid">11160211</pub-id></mixed-citation>
              </ref>
              <ref id="B9">
                <label>9</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Banks</surname><given-names>TA</given-names></string-name>, <string-name><surname>Rickert</surname><given-names>S</given-names></string-name>, <string-name><surname>Ware</surname><given-names>CF</given-names></string-name></person-group>. <year>2006</year>. <article-title>Restoring immune defenses via lymphotoxin signaling: lessons from cytomegalovirus</article-title>. <source>Immunol Res</source><volume>34</volume>:<fpage>243</fpage>–<lpage>254</lpage>. <pub-id pub-id-type="doi">10.1385/IR:34:3:243</pub-id>.<pub-id pub-id-type="pmid">16891674</pub-id></mixed-citation>
              </ref>
              <ref id="B10">
                <label>10</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Puglielli</surname><given-names>MT</given-names></string-name>, <string-name><surname>Browning</surname><given-names>JL</given-names></string-name>, <string-name><surname>Brewer</surname><given-names>AW</given-names></string-name>, <string-name><surname>Schreiber</surname><given-names>RD</given-names></string-name>, <string-name><surname>Shieh</surname><given-names>WJ</given-names></string-name>, <string-name><surname>Altman</surname><given-names>JD</given-names></string-name>, <string-name><surname>Oldstone</surname><given-names>MB</given-names></string-name>, <string-name><surname>Zaki</surname><given-names>SR</given-names></string-name>, <string-name><surname>Ahmed</surname><given-names>R</given-names></string-name></person-group>. <year>1999</year>. <article-title>Reversal of virus-induced systemic shock and respiratory failure by blockade of the lymphotoxin pathway</article-title>. <source>Nat Med</source><volume>5</volume>:<fpage>1370</fpage>–<lpage>1374</lpage>. <pub-id pub-id-type="doi">10.1038/70938</pub-id>.<pub-id pub-id-type="pmid">10581078</pub-id></mixed-citation>
              </ref>
              <ref id="B11">
                <label>11</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jin</surname><given-names>L</given-names></string-name>, <string-name><surname>Guo</surname><given-names>X</given-names></string-name>, <string-name><surname>Shen</surname><given-names>C</given-names></string-name>, <string-name><surname>Hao</surname><given-names>X</given-names></string-name>, <string-name><surname>Sun</surname><given-names>P</given-names></string-name>, <string-name><surname>Li</surname><given-names>P</given-names></string-name>, <string-name><surname>Xu</surname><given-names>T</given-names></string-name>, <string-name><surname>Hu</surname><given-names>C</given-names></string-name>, <string-name><surname>Rose</surname><given-names>O</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>H</given-names></string-name>, <string-name><surname>Yang</surname><given-names>M</given-names></string-name>, <string-name><surname>Qin</surname><given-names>CF</given-names></string-name>, <string-name><surname>Guo</surname><given-names>J</given-names></string-name>, <string-name><surname>Peng</surname><given-names>H</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>M</given-names></string-name>, <string-name><surname>Cheng</surname><given-names>G</given-names></string-name>, <string-name><surname>Qi</surname><given-names>X</given-names></string-name>, <string-name><surname>Lai</surname><given-names>R</given-names></string-name></person-group>. <year>2018</year>. <article-title>Salivary factor LTRIN from Aedes aegypti facilitates the transmission of Zika virus by interfering with the lymphotoxin-beta receptor</article-title>. <source>Nat Immunol</source><volume>19</volume>:<fpage>342</fpage>–<lpage>353</lpage>. <pub-id pub-id-type="doi">10.1038/s41590-018-0063-9</pub-id>.<pub-id pub-id-type="pmid">29507355</pub-id></mixed-citation>
              </ref>
              <ref id="B12">
                <label>12</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Behnke</surname><given-names>K</given-names></string-name>, <string-name><surname>Sorg</surname><given-names>UR</given-names></string-name>, <string-name><surname>Gabbert</surname><given-names>HE</given-names></string-name>, <string-name><surname>Pfeffer</surname><given-names>K</given-names></string-name></person-group>. <year>2017</year>. <article-title>The lymphotoxin beta receptor is essential for upregulation of IFN-induced guanylate-binding proteins and survival after Toxoplasma gondii infection</article-title>. <source>Mediators Inflamm</source><volume>2017</volume>:<fpage>7375818</fpage>. <pub-id pub-id-type="doi">10.1155/2017/7375818</pub-id>.<pub-id pub-id-type="pmid">28845089</pub-id></mixed-citation>
              </ref>
              <ref id="B13">
                <label>13</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hill</surname><given-names>DE</given-names></string-name>, <string-name><surname>Chirukandoth</surname><given-names>S</given-names></string-name>, <string-name><surname>Dubey</surname><given-names>JP</given-names></string-name></person-group>. <year>2005</year>. <article-title>Biology and epidemiology of Toxoplasma gondii in man and animals</article-title>. <source>Anim Health Res Rev</source><volume>6</volume>:<fpage>41</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1079/ahr2005100</pub-id>.<pub-id pub-id-type="pmid">16164008</pub-id></mixed-citation>
              </ref>
              <ref id="B14">
                <label>14</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Saadatnia</surname><given-names>G</given-names></string-name>, <string-name><surname>Golkar</surname><given-names>M</given-names></string-name></person-group>. <year>2012</year>. <article-title>A review on human toxoplasmosis</article-title>. <source>Scand J Infect Dis</source><volume>44</volume>:<fpage>805</fpage>–<lpage>814</lpage>. <pub-id pub-id-type="doi">10.3109/00365548.2012.693197</pub-id>.<pub-id pub-id-type="pmid">22831461</pub-id></mixed-citation>
              </ref>
              <ref id="B15">
                <label>15</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Montoya</surname><given-names>JG</given-names></string-name>, <string-name><surname>Liesenfeld</surname><given-names>O</given-names></string-name></person-group>. <year>2004</year>. <article-title>Toxoplasmosis</article-title>. <source>Lancet</source><volume>363</volume>:<fpage>1965</fpage>–<lpage>1976</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(04)16412-X</pub-id>.<pub-id pub-id-type="pmid">15194258</pub-id></mixed-citation>
              </ref>
              <ref id="B16">
                <label>16</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hakimi</surname><given-names>MA</given-names></string-name>, <string-name><surname>Olias</surname><given-names>P</given-names></string-name>, <string-name><surname>Sibley</surname><given-names>LD</given-names></string-name></person-group>. <year>2017</year>. <article-title>Toxoplasma effectors targeting host signaling and transcription</article-title>. <source>Clin Microbiol Rev</source><volume>30</volume>:<fpage>615</fpage>–<lpage>645</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.00005-17</pub-id>.<pub-id pub-id-type="pmid">28404792</pub-id></mixed-citation>
              </ref>
              <ref id="B17">
                <label>17</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Petersen</surname><given-names>E</given-names></string-name></person-group>. <year>2007</year>. <article-title>Toxoplasmosis</article-title>. <source>Semin Fetal Neonatal Med</source><volume>12</volume>:<fpage>214</fpage>–<lpage>223</lpage>. <pub-id pub-id-type="doi">10.1016/j.siny.2007.01.011</pub-id>.<pub-id pub-id-type="pmid">17321812</pub-id></mixed-citation>
              </ref>
              <ref id="B18">
                <label>18</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gaddi</surname><given-names>PJ</given-names></string-name>, <string-name><surname>Yap</surname><given-names>GS</given-names></string-name></person-group>. <year>2007</year>. <article-title>Cytokine regulation of immunopathology in toxoplasmosis</article-title>. <source>Immunol Cell Biol</source><volume>85</volume>:<fpage>155</fpage>–<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1038/sj.icb.7100038</pub-id>.<pub-id pub-id-type="pmid">17228318</pub-id></mixed-citation>
              </ref>
              <ref id="B19">
                <label>19</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Denkers</surname><given-names>EY</given-names></string-name></person-group>. <year>1999</year>. <article-title>T lymphocyte-dependent effector mechanisms of immunity to Toxoplasma gondii</article-title>. <source>Microbes Infect</source><volume>1</volume>:<fpage>699</fpage>–<lpage>708</lpage>. <pub-id pub-id-type="doi">10.1016/S1286-4579(99)80071-9</pub-id>.<pub-id pub-id-type="pmid">10611747</pub-id></mixed-citation>
              </ref>
              <ref id="B20">
                <label>20</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ivanova</surname><given-names>DL</given-names></string-name>, <string-name><surname>Denton</surname><given-names>SL</given-names></string-name>, <string-name><surname>Fettel</surname><given-names>KD</given-names></string-name>, <string-name><surname>Sondgeroth</surname><given-names>KS</given-names></string-name>, <string-name><surname>Munoz Gutierrez</surname><given-names>J</given-names></string-name>, <string-name><surname>Bangoura</surname><given-names>B</given-names></string-name>, <string-name><surname>Dunay</surname><given-names>IR</given-names></string-name>, <string-name><surname>Gigley</surname><given-names>JP</given-names></string-name></person-group>. <year>2019</year>. <article-title>Innate lymphoid cells in protection, pathology, and adaptive immunity during apicomplexan infection</article-title>. <source>Front Immunol</source><volume>10</volume>:<fpage>196</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.00196</pub-id>.<pub-id pub-id-type="pmid">30873151</pub-id></mixed-citation>
              </ref>
              <ref id="B21">
                <label>21</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Darwich</surname><given-names>L</given-names></string-name>, <string-name><surname>Coma</surname><given-names>G</given-names></string-name>, <string-name><surname>Pena</surname><given-names>R</given-names></string-name>, <string-name><surname>Bellido</surname><given-names>R</given-names></string-name>, <string-name><surname>Blanco</surname><given-names>EJ</given-names></string-name>, <string-name><surname>Este</surname><given-names>JA</given-names></string-name>, <string-name><surname>Borras</surname><given-names>FE</given-names></string-name>, <string-name><surname>Clotet</surname><given-names>B</given-names></string-name>, <string-name><surname>Ruiz</surname><given-names>L</given-names></string-name>, <string-name><surname>Rosell</surname><given-names>A</given-names></string-name>, <string-name><surname>Andreo</surname><given-names>F</given-names></string-name>, <string-name><surname>Parkhouse</surname><given-names>RM</given-names></string-name>, <string-name><surname>Bofill</surname><given-names>M</given-names></string-name></person-group>. <year>2009</year>. <article-title>Secretion of interferon-gamma by human macrophages demonstrated at the single-cell level after costimulation with interleukin (IL)-12 plus IL-18</article-title>. <source>Immunology</source><volume>126</volume>:<fpage>386</fpage>–<lpage>393</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2567.2008.02905.x</pub-id>.<pub-id pub-id-type="pmid">18759749</pub-id></mixed-citation>
              </ref>
              <ref id="B22">
                <label>22</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Suzuki</surname><given-names>Y</given-names></string-name>, <string-name><surname>Orellana</surname><given-names>MA</given-names></string-name>, <string-name><surname>Schreiber</surname><given-names>RD</given-names></string-name>, <string-name><surname>Remington</surname><given-names>JS</given-names></string-name></person-group>. <year>1988</year>. <article-title>Interferon-gamma: the major mediator of resistance against Toxoplasma gondii</article-title>. <source>Science</source><volume>240</volume>:<fpage>516</fpage>–<lpage>518</lpage>. <pub-id pub-id-type="doi">10.1126/science.3128869</pub-id>.<pub-id pub-id-type="pmid">3128869</pub-id></mixed-citation>
              </ref>
              <ref id="B23">
                <label>23</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yap</surname><given-names>GS</given-names></string-name>, <string-name><surname>Sher</surname><given-names>A</given-names></string-name></person-group>. <year>1999</year>. <article-title>Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function</article-title>. <source>Immunobiology</source><volume>201</volume>:<fpage>240</fpage>–<lpage>247</lpage>. <pub-id pub-id-type="doi">10.1016/S0171-2985(99)80064-3</pub-id>.<pub-id pub-id-type="pmid">10631573</pub-id></mixed-citation>
              </ref>
              <ref id="B24">
                <label>24</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Saeij</surname><given-names>JP</given-names></string-name>, <string-name><surname>Frickel</surname><given-names>EM</given-names></string-name></person-group>. <year>2017</year>. <article-title>Exposing Toxoplasma gondii hiding inside the vacuole: a role for GBPs, autophagy and host cell death</article-title>. <source>Curr Opin Microbiol</source><volume>40</volume>:<fpage>72</fpage>–<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.mib.2017.10.021</pub-id>.<pub-id pub-id-type="pmid">29141239</pub-id></mixed-citation>
              </ref>
              <ref id="B25">
                <label>25</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schluter</surname><given-names>D</given-names></string-name>, <string-name><surname>Kwok</surname><given-names>LY</given-names></string-name>, <string-name><surname>Lutjen</surname><given-names>S</given-names></string-name>, <string-name><surname>Soltek</surname><given-names>S</given-names></string-name>, <string-name><surname>Hoffmann</surname><given-names>S</given-names></string-name>, <string-name><surname>Korner</surname><given-names>H</given-names></string-name>, <string-name><surname>Deckert</surname><given-names>M</given-names></string-name></person-group>. <year>2003</year>. <article-title>Both lymphotoxin-alpha and TNF are crucial for control of Toxoplasma gondii in the central nervous system</article-title>. <source>J Immunol</source><volume>170</volume>:<fpage>6172</fpage>–<lpage>6182</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.170.12.6172</pub-id>.<pub-id pub-id-type="pmid">12794148</pub-id></mixed-citation>
              </ref>
              <ref id="B26">
                <label>26</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Daubener</surname><given-names>W</given-names></string-name>, <string-name><surname>Remscheid</surname><given-names>C</given-names></string-name>, <string-name><surname>Nockemann</surname><given-names>S</given-names></string-name>, <string-name><surname>Pilz</surname><given-names>K</given-names></string-name>, <string-name><surname>Seghrouchni</surname><given-names>S</given-names></string-name>, <string-name><surname>Mackenzie</surname><given-names>C</given-names></string-name>, <string-name><surname>Hadding</surname><given-names>U</given-names></string-name></person-group>. <year>1996</year>. <article-title>Anti-parasitic effector mechanisms in human brain tumor cells: role of interferon-gamma and tumor necrosis factor-alpha</article-title>. <source>Eur J Immunol</source><volume>26</volume>:<fpage>487</fpage>–<lpage>492</lpage>. <pub-id pub-id-type="doi">10.1002/eji.1830260231</pub-id>.<pub-id pub-id-type="pmid">8617321</pub-id></mixed-citation>
              </ref>
              <ref id="B27">
                <label>27</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fox</surname><given-names>BA</given-names></string-name>, <string-name><surname>Gigley</surname><given-names>JP</given-names></string-name>, <string-name><surname>Bzik</surname><given-names>DJ</given-names></string-name></person-group>. <year>2004</year>. <article-title>Toxoplasma gondii lacks the enzymes required for de novo arginine biosynthesis and arginine starvation triggers cyst formation</article-title>. <source>Int J Parasitol</source><volume>34</volume>:<fpage>323</fpage>–<lpage>331</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpara.2003.12.001</pub-id>.<pub-id pub-id-type="pmid">15003493</pub-id></mixed-citation>
              </ref>
              <ref id="B28">
                <label>28</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pfefferkorn</surname><given-names>ER</given-names></string-name>, <string-name><surname>Rebhun</surname><given-names>S</given-names></string-name>, <string-name><surname>Eckel</surname><given-names>M</given-names></string-name></person-group>. <year>1986</year>. <article-title>Characterization of an indoleamine 2,3-dioxygenase induced by gamma-interferon in cultured human fibroblasts</article-title>. <source>J Interferon Res</source><volume>6</volume>:<fpage>267</fpage>–<lpage>279</lpage>. <pub-id pub-id-type="doi">10.1089/jir.1986.6.267</pub-id>.<pub-id pub-id-type="pmid">2427623</pub-id></mixed-citation>
              </ref>
              <ref id="B29">
                <label>29</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Scharton-Kersten</surname><given-names>TM</given-names></string-name>, <string-name><surname>Yap</surname><given-names>G</given-names></string-name>, <string-name><surname>Magram</surname><given-names>J</given-names></string-name>, <string-name><surname>Sher</surname><given-names>A</given-names></string-name></person-group>. <year>1997</year>. <article-title>Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii</article-title>. <source>J Exp Med</source><volume>185</volume>:<fpage>1261</fpage>–<lpage>1273</lpage>. <pub-id pub-id-type="doi">10.1084/jem.185.7.1261</pub-id>.<pub-id pub-id-type="pmid">9104813</pub-id></mixed-citation>
              </ref>
              <ref id="B30">
                <label>30</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Degrandi</surname><given-names>D</given-names></string-name>, <string-name><surname>Konermann</surname><given-names>C</given-names></string-name>, <string-name><surname>Beuter-Gunia</surname><given-names>C</given-names></string-name>, <string-name><surname>Kresse</surname><given-names>A</given-names></string-name>, <string-name><surname>Wurthner</surname><given-names>J</given-names></string-name>, <string-name><surname>Kurig</surname><given-names>S</given-names></string-name>, <string-name><surname>Beer</surname><given-names>S</given-names></string-name>, <string-name><surname>Pfeffer</surname><given-names>K</given-names></string-name></person-group>. <year>2007</year>. <article-title>Extensive characterization of IFN-induced GTPases mGBP1 to mGBP10 involved in host defense</article-title>. <source>J Immunol</source><volume>179</volume>:<fpage>7729</fpage>–<lpage>7740</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.179.11.7729</pub-id>.<pub-id pub-id-type="pmid">18025219</pub-id></mixed-citation>
              </ref>
              <ref id="B31">
                <label>31</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Steffens</surname><given-names>N</given-names></string-name>, <string-name><surname>Beuter-Gunia</surname><given-names>C</given-names></string-name>, <string-name><surname>Kravets</surname><given-names>E</given-names></string-name>, <string-name><surname>Reich</surname><given-names>A</given-names></string-name>, <string-name><surname>Legewie</surname><given-names>L</given-names></string-name>, <string-name><surname>Pfeffer</surname><given-names>K</given-names></string-name>, <string-name><surname>Degrandi</surname><given-names>D</given-names></string-name></person-group>. <year>2020</year>. <article-title>Essential role of mGBP7 for survival of Toxoplasma gondii infection</article-title>. <source>mBio</source><volume>11</volume>:<elocation-id>e02993-19</elocation-id>.<pub-id pub-id-type="doi">10.1128/mBio.02993-19</pub-id>.</mixed-citation>
              </ref>
              <ref id="B32">
                <label>32</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yamamoto</surname><given-names>M</given-names></string-name>, <string-name><surname>Okuyama</surname><given-names>M</given-names></string-name>, <string-name><surname>Ma</surname><given-names>JS</given-names></string-name>, <string-name><surname>Kimura</surname><given-names>T</given-names></string-name>, <string-name><surname>Kamiyama</surname><given-names>N</given-names></string-name>, <string-name><surname>Saiga</surname><given-names>H</given-names></string-name>, <string-name><surname>Ohshima</surname><given-names>J</given-names></string-name>, <string-name><surname>Sasai</surname><given-names>M</given-names></string-name>, <string-name><surname>Kayama</surname><given-names>H</given-names></string-name>, <string-name><surname>Okamoto</surname><given-names>T</given-names></string-name>, <string-name><surname>Huang</surname><given-names>DC</given-names></string-name>, <string-name><surname>Soldati-Favre</surname><given-names>D</given-names></string-name>, <string-name><surname>Horie</surname><given-names>K</given-names></string-name>, <string-name><surname>Takeda</surname><given-names>J</given-names></string-name>, <string-name><surname>Takeda</surname><given-names>K</given-names></string-name></person-group>. <year>2012</year>. <article-title>A cluster of interferon-gamma-inducible p65 GTPases plays a critical role in host defense against Toxoplasma gondii</article-title>. <source>Immunity</source><volume>37</volume>:<fpage>302</fpage>–<lpage>313</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2012.06.009</pub-id>.<pub-id pub-id-type="pmid">22795875</pub-id></mixed-citation>
              </ref>
              <ref id="B33">
                <label>33</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Degrandi</surname><given-names>D</given-names></string-name>, <string-name><surname>Kravets</surname><given-names>E</given-names></string-name>, <string-name><surname>Konermann</surname><given-names>C</given-names></string-name>, <string-name><surname>Beuter-Gunia</surname><given-names>C</given-names></string-name>, <string-name><surname>Klumpers</surname><given-names>V</given-names></string-name>, <string-name><surname>Lahme</surname><given-names>S</given-names></string-name>, <string-name><surname>Wischmann</surname><given-names>E</given-names></string-name>, <string-name><surname>Mausberg</surname><given-names>AK</given-names></string-name>, <string-name><surname>Beer-Hammer</surname><given-names>S</given-names></string-name>, <string-name><surname>Pfeffer</surname><given-names>K</given-names></string-name></person-group>. <year>2013</year>. <article-title>Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii replication</article-title>. <source>Proc Natl Acad Sci U S A</source><volume>110</volume>:<fpage>294</fpage>–<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1205635110</pub-id>.<pub-id pub-id-type="pmid">23248289</pub-id></mixed-citation>
              </ref>
              <ref id="B34">
                <label>34</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Clough</surname><given-names>B</given-names></string-name>, <string-name><surname>Frickel</surname><given-names>EM</given-names></string-name></person-group>. <year>2017</year>. <article-title>The toxoplasma parasitophorous vacuole: an evolving host-parasite frontier</article-title>. <source>Trends Parasitol</source><volume>33</volume>:<fpage>473</fpage>–<lpage>488</lpage>. <pub-id pub-id-type="doi">10.1016/j.pt.2017.02.007</pub-id>.<pub-id pub-id-type="pmid">28330745</pub-id></mixed-citation>
              </ref>
              <ref id="B35">
                <label>35</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Selleck</surname><given-names>EM</given-names></string-name>, <string-name><surname>Fentress</surname><given-names>SJ</given-names></string-name>, <string-name><surname>Beatty</surname><given-names>WL</given-names></string-name>, <string-name><surname>Degrandi</surname><given-names>D</given-names></string-name>, <string-name><surname>Pfeffer</surname><given-names>K</given-names></string-name>, <string-name><surname>Virgin</surname><given-names>HW</given-names>, <suffix>IV</suffix></string-name>, <string-name><surname>Macmicking</surname><given-names>JD</given-names></string-name>, <string-name><surname>Sibley</surname><given-names>LD</given-names></string-name></person-group>. <year>2013</year>. <article-title>Guanylate-binding protein 1 (Gbp1) contributes to cell-autonomous immunity against Toxoplasma gondii</article-title>. <source>PLoS Pathog</source><volume>9</volume>:<elocation-id>e1003320</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1003320</pub-id>.<pub-id pub-id-type="pmid">23633952</pub-id></mixed-citation>
              </ref>
              <ref id="B36">
                <label>36</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kravets</surname><given-names>E</given-names></string-name>, <string-name><surname>Degrandi</surname><given-names>D</given-names></string-name>, <string-name><surname>Ma</surname><given-names>Q</given-names></string-name>, <string-name><surname>Peulen</surname><given-names>TO</given-names></string-name>, <string-name><surname>Klumpers</surname><given-names>V</given-names></string-name>, <string-name><surname>Felekyan</surname><given-names>S</given-names></string-name>, <string-name><surname>Kuhnemuth</surname><given-names>R</given-names></string-name>, <string-name><surname>Weidtkamp-Peters</surname><given-names>S</given-names></string-name>, <string-name><surname>Seidel</surname><given-names>CA</given-names></string-name>, <string-name><surname>Pfeffer</surname><given-names>K</given-names></string-name></person-group>. <year>2016</year>. <article-title>Guanylate binding proteins directly attack Toxoplasma gondii via supramolecular complexes</article-title>. <source>Elife</source><volume>5</volume>:<elocation-id>e11479</elocation-id>. <pub-id pub-id-type="doi">10.7554/eLife.11479</pub-id>.<pub-id pub-id-type="pmid">26814575</pub-id></mixed-citation>
              </ref>
              <ref id="B37">
                <label>37</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yap</surname><given-names>GS</given-names></string-name>, <string-name><surname>Scharton-Kersten</surname><given-names>T</given-names></string-name>, <string-name><surname>Charest</surname><given-names>H</given-names></string-name>, <string-name><surname>Sher</surname><given-names>A</given-names></string-name></person-group>. <year>1998</year>. <article-title>Decreased resistance of TNF receptor p55- and p75-deficient mice to chronic toxoplasmosis despite normal activation of inducible nitric oxide synthase in vivo</article-title>. <source>J Immunology</source><volume>160</volume>:<fpage>1340</fpage>–<lpage>1345</lpage>.<pub-id pub-id-type="pmid">9570552</pub-id></mixed-citation>
              </ref>
              <ref id="B38">
                <label>38</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Deckert-Schluter</surname><given-names>M</given-names></string-name>, <string-name><surname>Bluethmann</surname><given-names>H</given-names></string-name>, <string-name><surname>Rang</surname><given-names>A</given-names></string-name>, <string-name><surname>Hof</surname><given-names>H</given-names></string-name>, <string-name><surname>Schluter</surname><given-names>D</given-names></string-name></person-group>. <year>1998</year>. <article-title>Crucial role of TNF receptor type 1 (p55), but not of TNF receptor type 2 (p75), in murine toxoplasmosis</article-title>. <source>J Immunology</source><volume>160</volume>:<fpage>3427</fpage>–<lpage>3436</lpage>.<pub-id pub-id-type="pmid">9531303</pub-id></mixed-citation>
              </ref>
              <ref id="B39">
                <label>39</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Glatman Zaretsky</surname><given-names>A</given-names></string-name>, <string-name><surname>Silver</surname><given-names>JS</given-names></string-name>, <string-name><surname>Siwicki</surname><given-names>M</given-names></string-name>, <string-name><surname>Durham</surname><given-names>A</given-names></string-name>, <string-name><surname>Ware</surname><given-names>CF</given-names></string-name>, <string-name><surname>Hunter</surname><given-names>CA</given-names></string-name></person-group>. <year>2012</year>. <article-title>Infection with Toxoplasma gondii alters lymphotoxin expression associated with changes in splenic architecture</article-title>. <source>Infect Immun</source><volume>80</volume>:<fpage>3602</fpage>–<lpage>3610</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00333-12</pub-id>.<pub-id pub-id-type="pmid">22851754</pub-id></mixed-citation>
              </ref>
              <ref id="B40">
                <label>40</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gazzinelli</surname><given-names>RT</given-names></string-name>, <string-name><surname>Eltoum</surname><given-names>I</given-names></string-name>, <string-name><surname>Wynn</surname><given-names>TA</given-names></string-name>, <string-name><surname>Sher</surname><given-names>A</given-names></string-name></person-group>. <year>1993</year>. <article-title>Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation</article-title>. <source>J Immunol</source><volume>151</volume>:<fpage>3672</fpage>–<lpage>3681</lpage>.<pub-id pub-id-type="pmid">7690809</pub-id></mixed-citation>
              </ref>
              <ref id="B41">
                <label>41</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schaper</surname><given-names>F</given-names></string-name>, <string-name><surname>Rose-John</surname><given-names>S</given-names></string-name></person-group>. <year>2015</year>. <article-title>Interleukin-6: biology, signaling and strategies of blockade</article-title>. <source>Cytokine Growth Factor Rev</source><volume>26</volume>:<fpage>475</fpage>–<lpage>487</lpage>. <pub-id pub-id-type="doi">10.1016/j.cytogfr.2015.07.004</pub-id>.<pub-id pub-id-type="pmid">26189695</pub-id></mixed-citation>
              </ref>
              <ref id="B42">
                <label>42</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Saraiva</surname><given-names>M</given-names></string-name>, <string-name><surname>O’Garra</surname><given-names>A</given-names></string-name></person-group>. <year>2010</year>. <article-title>The regulation of IL-10 production by immune cells</article-title>. <source>Nat Rev Immunol</source><volume>10</volume>:<fpage>170</fpage>–<lpage>181</lpage>. <pub-id pub-id-type="doi">10.1038/nri2711</pub-id>.<pub-id pub-id-type="pmid">20154735</pub-id></mixed-citation>
              </ref>
              <ref id="B43">
                <label>43</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brenier-Pinchart</surname><given-names>MP</given-names></string-name>, <string-name><surname>Villena</surname><given-names>I</given-names></string-name>, <string-name><surname>Mercier</surname><given-names>C</given-names></string-name>, <string-name><surname>Durand</surname><given-names>F</given-names></string-name>, <string-name><surname>Simon</surname><given-names>J</given-names></string-name>, <string-name><surname>Cesbron-Delauw</surname><given-names>MF</given-names></string-name>, <string-name><surname>Pelloux</surname><given-names>H</given-names></string-name></person-group>. <year>2006</year>. <article-title>The Toxoplasma surface protein SAG1 triggers efficient in vitro secretion of chemokine ligand 2 (CCL2) from human fibroblasts</article-title>. <source>Microbes Infect</source><volume>8</volume>:<fpage>254</fpage>–<lpage>261</lpage>. <pub-id pub-id-type="doi">10.1016/j.micinf.2005.06.023</pub-id>.<pub-id pub-id-type="pmid">16213182</pub-id></mixed-citation>
              </ref>
              <ref id="B44">
                <label>44</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Singhania</surname><given-names>A</given-names></string-name>, <string-name><surname>Graham</surname><given-names>CM</given-names></string-name>, <string-name><surname>Gabrysova</surname><given-names>L</given-names></string-name>, <string-name><surname>Moreira-Teixeira</surname><given-names>L</given-names></string-name>, <string-name><surname>Stavropoulos</surname><given-names>E</given-names></string-name>, <string-name><surname>Pitt</surname><given-names>JM</given-names></string-name>, <string-name><surname>Chakravarty</surname><given-names>P</given-names></string-name>, <string-name><surname>Warnatsch</surname><given-names>A</given-names></string-name>, <string-name><surname>Branchett</surname><given-names>WJ</given-names></string-name>, <string-name><surname>Conejero</surname><given-names>L</given-names></string-name>, <string-name><surname>Lin</surname><given-names>JW</given-names></string-name>, <string-name><surname>Davidson</surname><given-names>S</given-names></string-name>, <string-name><surname>Wilson</surname><given-names>MS</given-names></string-name>, <string-name><surname>Bancroft</surname><given-names>G</given-names></string-name>, <string-name><surname>Langhorne</surname><given-names>J</given-names></string-name>, <string-name><surname>Frickel</surname><given-names>E</given-names></string-name>, <string-name><surname>Sesay</surname><given-names>AK</given-names></string-name>, <string-name><surname>Priestnall</surname><given-names>SL</given-names></string-name>, <string-name><surname>Herbert</surname><given-names>E</given-names></string-name>, <string-name><surname>Ioannou</surname><given-names>M</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Q</given-names></string-name>, <string-name><surname>Humphreys</surname><given-names>IR</given-names></string-name>, <string-name><surname>Dodd</surname><given-names>J</given-names></string-name>, <string-name><surname>Openshaw</surname><given-names>PJM</given-names></string-name>, <string-name><surname>Mayer-Barber</surname><given-names>KD</given-names></string-name>, <string-name><surname>Jankovic</surname><given-names>D</given-names></string-name>, <string-name><surname>Sher</surname><given-names>A</given-names></string-name>, <string-name><surname>Lloyd</surname><given-names>CM</given-names></string-name>, <string-name><surname>Baldwin</surname><given-names>N</given-names></string-name>, <string-name><surname>Chaussabel</surname><given-names>D</given-names></string-name>, <string-name><surname>Papayannopoulos</surname><given-names>V</given-names></string-name>, <string-name><surname>Wack</surname><given-names>A</given-names></string-name>, <string-name><surname>Banchereau</surname><given-names>JF</given-names></string-name>, <string-name><surname>Pascual</surname><given-names>VM</given-names></string-name>, <string-name><surname>O’Garra</surname><given-names>A</given-names></string-name></person-group>. <year>2019</year>. <article-title>Transcriptional profiling unveils type I and II interferon networks in blood and tissues across diseases</article-title>. <source>Nat Commun</source><volume>10</volume>:<fpage>2887</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-019-10601-6</pub-id>.<pub-id pub-id-type="pmid">31253760</pub-id></mixed-citation>
              </ref>
              <ref id="B45">
                <label>45</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yarovinsky</surname><given-names>F</given-names></string-name></person-group>. <year>2014</year>. <article-title>Innate immunity to Toxoplasma gondii infection</article-title>. <source>Nat Rev Immunol</source><volume>14</volume>:<fpage>109</fpage>–<lpage>121</lpage>. <pub-id pub-id-type="doi">10.1038/nri3598</pub-id>.<pub-id pub-id-type="pmid">24457485</pub-id></mixed-citation>
              </ref>
              <ref id="B46">
                <label>46</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ratna</surname><given-names>A</given-names></string-name>, <string-name><surname>Arora</surname><given-names>SK</given-names></string-name></person-group>. <year>2016</year>. <article-title>Leishmania recombinant antigen modulates macrophage effector function facilitating early clearance of intracellular parasites</article-title>. <source>Trans R Soc Trop Med Hyg</source><volume>110</volume>:<fpage>610</fpage>–<lpage>619</lpage>. <pub-id pub-id-type="doi">10.1093/trstmh/trw068</pub-id>.<pub-id pub-id-type="pmid">27941165</pub-id></mixed-citation>
              </ref>
              <ref id="B47">
                <label>47</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Koo</surname><given-names>SJ</given-names></string-name>, <string-name><surname>Chowdhury</surname><given-names>IH</given-names></string-name>, <string-name><surname>Szczesny</surname><given-names>B</given-names></string-name>, <string-name><surname>Wan</surname><given-names>X</given-names></string-name>, <string-name><surname>Garg</surname><given-names>NJ</given-names></string-name></person-group>. <year>2016</year>. <article-title>Macrophages promote oxidative metabolism to drive nitric oxide generation in response to Trypanosoma cruzi</article-title>. <source>Infect Immun</source><volume>84</volume>:<fpage>3527</fpage>–<lpage>3541</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00809-16</pub-id>.<pub-id pub-id-type="pmid">27698021</pub-id></mixed-citation>
              </ref>
              <ref id="B48">
                <label>48</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ufermann</surname><given-names>CM</given-names></string-name>, <string-name><surname>Domrose</surname><given-names>A</given-names></string-name>, <string-name><surname>Babel</surname><given-names>T</given-names></string-name>, <string-name><surname>Tersteegen</surname><given-names>A</given-names></string-name>, <string-name><surname>Cengiz</surname><given-names>SC</given-names></string-name>, <string-name><surname>Eller</surname><given-names>SK</given-names></string-name>, <string-name><surname>Spekker-Bosker</surname><given-names>K</given-names></string-name>, <string-name><surname>Sorg</surname><given-names>UR</given-names></string-name>, <string-name><surname>Forster</surname><given-names>I</given-names></string-name>, <string-name><surname>Daubener</surname><given-names>W</given-names></string-name></person-group>. <year>2019</year>. <article-title>Indoleamine 2,3-dioxygenase activity during acute toxoplasmosis and the suppressed T cell proliferation in mice</article-title>. <source>Front Cell Infect Microbiol</source><volume>9</volume>:<fpage>184</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2019.00184</pub-id>.<pub-id pub-id-type="pmid">31231617</pub-id></mixed-citation>
              </ref>
              <ref id="B49">
                <label>49</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pittman</surname><given-names>KJ</given-names></string-name>, <string-name><surname>Knoll</surname><given-names>LJ</given-names></string-name></person-group>. <year>2015</year>. <article-title>Long-Term Relationships: the Complicated Interplay between the Host and the Developmental Stages of Toxoplasma gondii during Acute and Chronic Infections</article-title>. <source>Microbiol Mol Biol Rev</source><volume>79</volume>:<fpage>387</fpage>–<lpage>401</lpage>. <pub-id pub-id-type="doi">10.1128/MMBR.00027-15</pub-id>.<pub-id pub-id-type="pmid">26335719</pub-id></mixed-citation>
              </ref>
              <ref id="B50">
                <label>50</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sher</surname><given-names>A</given-names></string-name>, <string-name><surname>Denkers</surname><given-names>EY</given-names></string-name>, <string-name><surname>Gazzinelli</surname><given-names>RT</given-names></string-name></person-group>. <year>1995</year>. <article-title>Induction and regulation of host cell-mediated immunity by Toxoplasma gondii</article-title>. <source>Ciba Found Symp</source><volume>195</volume>:<fpage>95</fpage>–<lpage>104</lpage>. <comment>discussion 104–9</comment>. <pub-id pub-id-type="doi">10.1002/9780470514849.ch7</pub-id>.<pub-id pub-id-type="pmid">8724832</pub-id></mixed-citation>
              </ref>
              <ref id="B51">
                <label>51</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Park</surname><given-names>E</given-names></string-name>, <string-name><surname>Patel</surname><given-names>S</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Q</given-names></string-name>, <string-name><surname>Andhey</surname><given-names>P</given-names></string-name>, <string-name><surname>Zaitsev</surname><given-names>K</given-names></string-name>, <string-name><surname>Porter</surname><given-names>S</given-names></string-name>, <string-name><surname>Hershey</surname><given-names>M</given-names></string-name>, <string-name><surname>Bern</surname><given-names>M</given-names></string-name>, <string-name><surname>Plougastel-Douglas</surname><given-names>B</given-names></string-name>, <string-name><surname>Collins</surname><given-names>P</given-names></string-name>, <string-name><surname>Colonna</surname><given-names>M</given-names></string-name>, <string-name><surname>Murphy</surname><given-names>KM</given-names></string-name>, <string-name><surname>Oltz</surname><given-names>E</given-names></string-name>, <string-name><surname>Artyomov</surname><given-names>M</given-names></string-name>, <string-name><surname>Sibley</surname><given-names>LD</given-names></string-name>, <string-name><surname>Yokoyama</surname><given-names>WM</given-names></string-name></person-group>. <year>2019</year>. <article-title>Toxoplasma gondii infection drives conversion of NK cells into ILC1-like cells</article-title>. <source>Elife</source><volume>8</volume>:<fpage>95</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.47605</pub-id>.</mixed-citation>
              </ref>
              <ref id="B52">
                <label>52</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vallabhapurapu</surname><given-names>S</given-names></string-name>, <string-name><surname>Powolny-Budnicka</surname><given-names>I</given-names></string-name>, <string-name><surname>Riemann</surname><given-names>M</given-names></string-name>, <string-name><surname>Schmid</surname><given-names>RM</given-names></string-name>, <string-name><surname>Paxian</surname><given-names>S</given-names></string-name>, <string-name><surname>Pfeffer</surname><given-names>K</given-names></string-name>, <string-name><surname>Korner</surname><given-names>H</given-names></string-name>, <string-name><surname>Weih</surname><given-names>F</given-names></string-name></person-group>. <year>2008</year>. <article-title>Rel/NF-kappaB family member RelA regulates NK1.1- to NK1.1+ transition as well as IL-15-induced expansion of NKT cells</article-title>. <source>Eur J Immunol</source><volume>38</volume>:<fpage>3508</fpage>–<lpage>3519</lpage>. <pub-id pub-id-type="doi">10.1002/eji.200737830</pub-id>.<pub-id pub-id-type="pmid">19003818</pub-id></mixed-citation>
              </ref>
              <ref id="B53">
                <label>53</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Deckert-Schluter</surname><given-names>M</given-names></string-name>, <string-name><surname>Rang</surname><given-names>A</given-names></string-name>, <string-name><surname>Weiner</surname><given-names>D</given-names></string-name>, <string-name><surname>Huang</surname><given-names>S</given-names></string-name>, <string-name><surname>Wiestler</surname><given-names>OD</given-names></string-name>, <string-name><surname>Hof</surname><given-names>H</given-names></string-name>, <string-name><surname>Schluter</surname><given-names>D</given-names></string-name></person-group>. <year>1996</year>. <article-title>Interferon-gamma receptor-deficiency renders mice highly susceptible to toxoplasmosis by decreased macrophage activation</article-title>. <source>Lab Invest</source><volume>75</volume>:<fpage>827</fpage>–<lpage>841</lpage>.<pub-id pub-id-type="pmid">8973478</pub-id></mixed-citation>
              </ref>
              <ref id="B54">
                <label>54</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Kim</surname><given-names>TJ</given-names></string-name>, <string-name><surname>Wroblewska</surname><given-names>JA</given-names></string-name>, <string-name><surname>Tesic</surname><given-names>V</given-names></string-name>, <string-name><surname>Upadhyay</surname><given-names>V</given-names></string-name>, <string-name><surname>Weichselbaum</surname><given-names>RR</given-names></string-name>, <string-name><surname>Tumanov</surname><given-names>AV</given-names></string-name>, <string-name><surname>Tang</surname><given-names>H</given-names></string-name>, <string-name><surname>Guo</surname><given-names>X</given-names></string-name>, <string-name><surname>Tang</surname><given-names>H</given-names></string-name>, <string-name><surname>Fu</surname><given-names>YX</given-names></string-name></person-group>. <year>2018</year>. <article-title>Type 3 innate lymphoid cell-derived lymphotoxin prevents microbiota-dependent inflammation</article-title>. <source>Cell Mol Immunol</source><volume>15</volume>:<fpage>697</fpage>–<lpage>709</lpage>. <pub-id pub-id-type="doi">10.1038/cmi.2017.25</pub-id>.<pub-id pub-id-type="pmid">28579615</pub-id></mixed-citation>
              </ref>
              <ref id="B55">
                <label>55</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gazzinelli</surname><given-names>RT</given-names></string-name>, <string-name><surname>Wysocka</surname><given-names>M</given-names></string-name>, <string-name><surname>Hieny</surname><given-names>S</given-names></string-name>, <string-name><surname>Scharton-Kersten</surname><given-names>T</given-names></string-name>, <string-name><surname>Cheever</surname><given-names>A</given-names></string-name>, <string-name><surname>Kuhn</surname><given-names>R</given-names></string-name>, <string-name><surname>Muller</surname><given-names>W</given-names></string-name>, <string-name><surname>Trinchieri</surname><given-names>G</given-names></string-name>, <string-name><surname>Sher</surname><given-names>A</given-names></string-name></person-group>. <year>1996</year>. <article-title>In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha</article-title>. <source>J Immunol</source><volume>157</volume>:<fpage>798</fpage>–<lpage>805</lpage>.<pub-id pub-id-type="pmid">8752931</pub-id></mixed-citation>
              </ref>
              <ref id="B56">
                <label>56</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Frey</surname><given-names>RS</given-names></string-name>, <string-name><surname>Rahman</surname><given-names>A</given-names></string-name>, <string-name><surname>Kefer</surname><given-names>JC</given-names></string-name>, <string-name><surname>Minshall</surname><given-names>RD</given-names></string-name>, <string-name><surname>Malik</surname><given-names>AB</given-names></string-name></person-group>. <year>2002</year>. <article-title>PKCzeta regulates TNF-alpha-induced activation of NADPH oxidase in endothelial cells</article-title>. <source>Circ Res</source><volume>90</volume>:<fpage>1012</fpage>–<lpage>1019</lpage>. <pub-id pub-id-type="doi">10.1161/01.res.0000017631.28815.8e</pub-id>.<pub-id pub-id-type="pmid">12016268</pub-id></mixed-citation>
              </ref>
              <ref id="B57">
                <label>57</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ziltener</surname><given-names>P</given-names></string-name>, <string-name><surname>Reinheckel</surname><given-names>T</given-names></string-name>, <string-name><surname>Oxenius</surname><given-names>A</given-names></string-name></person-group>. <year>2016</year>. <article-title>Neutrophil and alveolar macrophage-mediated innate immune control of Legionella pneumophila lung infection via TNF and ROS</article-title>. <source>PLoS Pathog</source><volume>12</volume>:<elocation-id>e1005591</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1005591</pub-id>.<pub-id pub-id-type="pmid">27105352</pub-id></mixed-citation>
              </ref>
              <ref id="B58">
                <label>58</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ohshima</surname><given-names>J</given-names></string-name>, <string-name><surname>Lee</surname><given-names>Y</given-names></string-name>, <string-name><surname>Sasai</surname><given-names>M</given-names></string-name>, <string-name><surname>Saitoh</surname><given-names>T</given-names></string-name>, <string-name><surname>Su Ma</surname><given-names>J</given-names></string-name>, <string-name><surname>Kamiyama</surname><given-names>N</given-names></string-name>, <string-name><surname>Matsuura</surname><given-names>Y</given-names></string-name>, <string-name><surname>Pann-Ghill</surname><given-names>S</given-names></string-name>, <string-name><surname>Hayashi</surname><given-names>M</given-names></string-name>, <string-name><surname>Ebisu</surname><given-names>S</given-names></string-name>, <string-name><surname>Takeda</surname><given-names>K</given-names></string-name>, <string-name><surname>Akira</surname><given-names>S</given-names></string-name>, <string-name><surname>Yamamoto</surname><given-names>M</given-names></string-name></person-group>. <year>2014</year>. <article-title>Role of mouse and human autophagy proteins in IFN-gamma-induced cell-autonomous responses against Toxoplasma gondii</article-title>. <source>J Immunol</source><volume>192</volume>:<fpage>3328</fpage>–<lpage>3335</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1302822</pub-id>.<pub-id pub-id-type="pmid">24563254</pub-id></mixed-citation>
              </ref>
              <ref id="B59">
                <label>59</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kisseleva</surname><given-names>T</given-names></string-name>, <string-name><surname>Bhattacharya</surname><given-names>S</given-names></string-name>, <string-name><surname>Braunstein</surname><given-names>J</given-names></string-name>, <string-name><surname>Schindler</surname><given-names>CW</given-names></string-name></person-group>. <year>2002</year>. <article-title>Signaling through the JAK/STAT pathway, recent advances and future challenges</article-title>. <source>Gene</source><volume>285</volume>:<fpage>1</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/s0378-1119(02)00398-0</pub-id>.<pub-id pub-id-type="pmid">12039028</pub-id></mixed-citation>
              </ref>
              <ref id="B60">
                <label>60</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Greenlund</surname><given-names>AC</given-names></string-name>, <string-name><surname>Farrar</surname><given-names>MA</given-names></string-name>, <string-name><surname>Viviano</surname><given-names>BL</given-names></string-name>, <string-name><surname>Schreiber</surname><given-names>RD</given-names></string-name></person-group>. <year>1994</year>. <article-title>Ligand-induced IFN gamma receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91)</article-title>. <source>EMBO J</source><volume>13</volume>:<fpage>1591</fpage>–<lpage>1600</lpage>. <pub-id pub-id-type="doi">10.1002/j.1460-2075.1994.tb06422.x</pub-id>.<pub-id pub-id-type="pmid">8156998</pub-id></mixed-citation>
              </ref>
              <ref id="B61">
                <label>61</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kutsch</surname><given-names>S</given-names></string-name>, <string-name><surname>Degrandi</surname><given-names>D</given-names></string-name>, <string-name><surname>Pfeffer</surname><given-names>K</given-names></string-name></person-group>. <year>2008</year>. <article-title>Immediate lymphotoxin beta receptor-mediated transcriptional response in host defense against L. monocytogenes</article-title>. <source>Immunobiology</source><volume>213</volume>:<fpage>353</fpage>–<lpage>366</lpage>. <pub-id pub-id-type="doi">10.1016/j.imbio.2007.10.011</pub-id>.<pub-id pub-id-type="pmid">18406380</pub-id></mixed-citation>
              </ref>
              <ref id="B62">
                <label>62</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Franki</surname><given-names>AS</given-names></string-name>, <string-name><surname>Van Beneden</surname><given-names>K</given-names></string-name>, <string-name><surname>Dewint</surname><given-names>P</given-names></string-name>, <string-name><surname>Hammond</surname><given-names>KJ</given-names></string-name>, <string-name><surname>Lambrecht</surname><given-names>S</given-names></string-name>, <string-name><surname>Leclercq</surname><given-names>G</given-names></string-name>, <string-name><surname>Kronenberg</surname><given-names>M</given-names></string-name>, <string-name><surname>Deforce</surname><given-names>D</given-names></string-name>, <string-name><surname>Elewaut</surname><given-names>D</given-names></string-name></person-group>. <year>2006</year>. <article-title>A unique lymphotoxin {alpha}beta-dependent pathway regulates thymic emigration of V{alpha}14 invariant natural killer T cells</article-title>. <source>Proc Natl Acad Sci U S A</source><volume>103</volume>:<fpage>9160</fpage>–<lpage>9165</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0508892103</pub-id>.<pub-id pub-id-type="pmid">16751279</pub-id></mixed-citation>
              </ref>
              <ref id="B63">
                <label>63</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ronet</surname><given-names>C</given-names></string-name>, <string-name><surname>Darche</surname><given-names>S</given-names></string-name>, <string-name><surname>Leite de Moraes</surname><given-names>M</given-names></string-name>, <string-name><surname>Miyake</surname><given-names>S</given-names></string-name>, <string-name><surname>Yamamura</surname><given-names>T</given-names></string-name>, <string-name><surname>Louis</surname><given-names>JA</given-names></string-name>, <string-name><surname>Kasper</surname><given-names>LH</given-names></string-name>, <string-name><surname>Buzoni-Gatel</surname><given-names>D</given-names></string-name></person-group>. <year>2005</year>. <article-title>NKT cells are critical for the initiation of an inflammatory bowel response against Toxoplasma gondii</article-title>. <source>J Immunol</source><volume>175</volume>:<fpage>899</fpage>–<lpage>908</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.175.2.899</pub-id>.<pub-id pub-id-type="pmid">16002688</pub-id></mixed-citation>
              </ref>
              <ref id="B64">
                <label>64</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nakano</surname><given-names>Y</given-names></string-name>, <string-name><surname>Hisaeda</surname><given-names>H</given-names></string-name>, <string-name><surname>Sakai</surname><given-names>T</given-names></string-name>, <string-name><surname>Ishikawa</surname><given-names>H</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>M</given-names></string-name>, <string-name><surname>Maekawa</surname><given-names>Y</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>T</given-names></string-name>, <string-name><surname>Takashima</surname><given-names>M</given-names></string-name>, <string-name><surname>Nishitani</surname><given-names>M</given-names></string-name>, <string-name><surname>Good</surname><given-names>RA</given-names></string-name>, <string-name><surname>Himeno</surname><given-names>K</given-names></string-name></person-group>. <year>2002</year>. <article-title>Roles of NKT cells in resistance against infection with Toxoplasma gondii and in expression of heat shock protein 65 in the host macrophages</article-title>. <source>Microbes Infect</source><volume>4</volume>:<fpage>1</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/s1286-4579(01)01503-9</pub-id>.<pub-id pub-id-type="pmid">11825769</pub-id></mixed-citation>
              </ref>
              <ref id="B65">
                <label>65</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Paludan</surname><given-names>SR</given-names></string-name></person-group>. <year>1998</year>. <article-title>Interleukin-4 and interferon-gamma: the quintessence of a mutual antagonistic relationship</article-title>. <source>Scand J Immunol</source><volume>48</volume>:<fpage>459</fpage>–<lpage>468</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-3083.1998.00435.x</pub-id>.<pub-id pub-id-type="pmid">9822252</pub-id></mixed-citation>
              </ref>
              <ref id="B66">
                <label>66</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>De Togni</surname><given-names>P</given-names></string-name>, <string-name><surname>Goellner</surname><given-names>J</given-names></string-name>, <string-name><surname>Ruddle</surname><given-names>NH</given-names></string-name>, <string-name><surname>Streeter</surname><given-names>PR</given-names></string-name>, <string-name><surname>Fick</surname><given-names>A</given-names></string-name>, <string-name><surname>Mariathasan</surname><given-names>S</given-names></string-name>, <string-name><surname>Smith</surname><given-names>SC</given-names></string-name>, <string-name><surname>Carlson</surname><given-names>R</given-names></string-name>, <string-name><surname>Shornick</surname><given-names>LP</given-names></string-name>, <string-name><surname>Strauss-Schoenberger</surname><given-names>J</given-names></string-name></person-group>. <year>1994</year>. <article-title>Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin</article-title>. <source>Science</source><volume>264</volume>:<fpage>703</fpage>–<lpage>707</lpage>. <pub-id pub-id-type="doi">10.1126/science.8171322</pub-id>.<pub-id pub-id-type="pmid">8171322</pub-id></mixed-citation>
              </ref>
              <ref id="B67">
                <label>67</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sibley</surname><given-names>LD</given-names></string-name>, <string-name><surname>Boothroyd</surname><given-names>JC</given-names></string-name></person-group>. <year>1992</year>. <article-title>Virulent strains of Toxoplasma gondii comprise a single clonal lineage</article-title>. <source>Nature</source><volume>359</volume>:<fpage>82</fpage>–<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1038/359082a0</pub-id>.<pub-id pub-id-type="pmid">1355855</pub-id></mixed-citation>
              </ref>
              <ref id="B68">
                <label>68</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Howe</surname><given-names>DK</given-names></string-name>, <string-name><surname>Sibley</surname><given-names>LD</given-names></string-name></person-group>. <year>1995</year>. <article-title>Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease</article-title>. <source>J Infect Dis</source><volume>172</volume>:<fpage>1561</fpage>–<lpage>1566</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/172.6.1561</pub-id>.<pub-id pub-id-type="pmid">7594717</pub-id></mixed-citation>
              </ref>
              <ref id="B69">
                <label>69</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Howe</surname><given-names>DK</given-names></string-name>, <string-name><surname>Honore</surname><given-names>S</given-names></string-name>, <string-name><surname>Derouin</surname><given-names>F</given-names></string-name>, <string-name><surname>Sibley</surname><given-names>LD</given-names></string-name></person-group>. <year>1997</year>. <article-title>Determination of genotypes of Toxoplasma gondii strains isolated from patients with toxoplasmosis</article-title>. <source>J Clin Microbiol</source><volume>35</volume>:<fpage>1411</fpage>–<lpage>1414</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.35.6.1411-1414.1997</pub-id>.<pub-id pub-id-type="pmid">9163454</pub-id></mixed-citation>
              </ref>
              <ref id="B70">
                <label>70</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schlüter</surname><given-names>D</given-names></string-name>, <string-name><surname>Däubener</surname><given-names>W</given-names></string-name>, <string-name><surname>Schares</surname><given-names>G</given-names></string-name>, <string-name><surname>Groß</surname><given-names>U</given-names></string-name>, <string-name><surname>Pleyer</surname><given-names>U</given-names></string-name>, <string-name><surname>Lüder</surname><given-names>C</given-names></string-name></person-group>. <year>2014</year>. <article-title>Animals are key to human toxoplasmosis</article-title>. <source>Int J Med Microbiol</source><volume>304</volume>:<fpage>917</fpage>–<lpage>929</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijmm.2014.09.002</pub-id>.<pub-id pub-id-type="pmid">25240467</pub-id></mixed-citation>
              </ref>
              <ref id="B71">
                <label>71</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kang</surname><given-names>H</given-names></string-name>, <string-name><surname>Remington</surname><given-names>JS</given-names></string-name>, <string-name><surname>Suzuki</surname><given-names>Y</given-names></string-name></person-group>. <year>2000</year>. <article-title>Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase</article-title>. <source>J Immunol</source><volume>164</volume>:<fpage>2629</fpage>–<lpage>2634</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.164.5.2629</pub-id>.<pub-id pub-id-type="pmid">10679102</pub-id></mixed-citation>
              </ref>
              <ref id="B72">
                <label>72</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schluter</surname><given-names>D</given-names></string-name>, <string-name><surname>Deckert</surname><given-names>M</given-names></string-name>, <string-name><surname>Hof</surname><given-names>H</given-names></string-name>, <string-name><surname>Frei</surname><given-names>K</given-names></string-name></person-group>. <year>2001</year>. <article-title>Toxoplasma gondii infection of neurons induces neuronal cytokine and chemokine production, but gamma interferon- and tumor necrosis factor-stimulated neurons fail to inhibit the invasion and growth of T. gondii</article-title>. <source>Infect Immun</source><volume>69</volume>:<fpage>7889</fpage>–<lpage>7893</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.69.12.7889-7893.2001</pub-id>.<pub-id pub-id-type="pmid">11705972</pub-id></mixed-citation>
              </ref>
              <ref id="B73">
                <label>73</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhu</surname><given-names>W</given-names></string-name>, <string-name><surname>Li</surname><given-names>J</given-names></string-name>, <string-name><surname>Pappoe</surname><given-names>F</given-names></string-name>, <string-name><surname>Shen</surname><given-names>J</given-names></string-name>, <string-name><surname>Yu</surname><given-names>L</given-names></string-name></person-group>. <year>2019</year>. <article-title>Strategies developed by Toxoplasma gondii to survive in the host</article-title>. <source>Front Microbiol</source><volume>10</volume>:<fpage>899</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2019.00899</pub-id>.<pub-id pub-id-type="pmid">31080445</pub-id></mixed-citation>
              </ref>
              <ref id="B74">
                <label>74</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Virgen-Slane</surname><given-names>R</given-names></string-name>, <string-name><surname>Correa</surname><given-names>RG</given-names></string-name>, <string-name><surname>Ramezani-Rad</surname><given-names>P</given-names></string-name>, <string-name><surname>Steen-Fuentes</surname><given-names>S</given-names></string-name>, <string-name><surname>Detanico</surname><given-names>T</given-names></string-name>, <string-name><surname>DiCandido</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Li</surname><given-names>J</given-names></string-name>, <string-name><surname>Ware</surname><given-names>CF</given-names></string-name></person-group>. <year>2020</year>. <article-title>Cutting edge: the RNA-binding protein Ewing sarcoma is a novel modulator of lymphotoxin beta receptor signaling</article-title>. <source>J Immunol</source><volume>204</volume>:<fpage>1085</fpage>–<lpage>1090</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1901260</pub-id>.<pub-id pub-id-type="pmid">31969387</pub-id></mixed-citation>
              </ref>
              <ref id="B75">
                <label>75</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>TJ</given-names></string-name>, <string-name><surname>Kotecha</surname><given-names>N</given-names></string-name></person-group>. <year>2014</year>. <article-title>Cytobank: providing an analytics platform for community cytometry data analysis and collaboration</article-title>. <source>Curr Top Microbiol Immunol</source><volume>377</volume>:<fpage>127</fpage>–<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1007/82_2014_364</pub-id>.<pub-id pub-id-type="pmid">24590675</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
